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SUMMARY 
T cells recognizing myelin auto-antigens penetrate into the CNS to induce 
inflammatory autoimmune disease following complex sequential interactions with 
individual components of the vascular blood-brain barrier (BBB), particularly 
endothelial cells, and perivascular phagocytes. To determine the functional 
consequences of these processes, two-photon intravital imaging was performed to 
compare the behavior of three myelin-specific GFP-expressing T cell lines with 
different potentials for transferring Experimental Autoimmune Encephalomyelitis. 
Imaging documented that, irrespective of their pathogenic potential, all T cell lines 
reached the CNS and interacted with vascular endothelial cells indistinguishably, 
crawling on the luminal surface, preferably against blood flow, before crossing the 
vessel wall. In striking contrast, after extravasation the T cell motility and their 
interactions with perivascular antigen presenting cells (APCs) varied dramatically. 
While highly encephalitogenic T cells showed a low motility, made stable contacts 
with local APCs and became activated, the corresponding contacts of weakly 
encephalitogenic T cells remained short, their motility high and their activation 
marginal. Supplying auto-antigen, via either local injection or by transfer of antigen-
pulsed meningeal APCs, lowered their motility and prolonged the contact duration of 
weakly encephalitogenic T cells to values characteristic for highly pathogenic ones. 
Only after exogenous antigen supply, the weakly encephalitogenic T cells became 
activated, infiltrated the CNS parenchyma, and triggered clinical EAE, suggesting 
that the strength of the antigen-dependent signals received by immigrating effector 
T cells from leptomeningeal APCs is crucial for their pathogenic effect within the 
target tissue. 
To directly correlate the activation of encephalitogenic T cells with their dynamic 
behavior in the CNS, a truncated fluorescent derivative of nuclear factor of activated 
T cells (NFAT) was introduced as a real-time activation indicator. Two-photon 
imaging documented the activation of the auto-reactive T cells extravasated into the 
perivascular space, but not within the vascular lumen. Activation correlated with 
reduced T cell motility, and it was related to contacts with the local APCs. However, 
it did not necessarily lead to a long-lasting arrest, as individual, activated T cells 
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were able to sequentially contact other APCs. A spontaneous cytosol-nuclear 
translocation of the marker was noted only in T cells with a high pathogenic potential. 
The translocation implied the presentation of an auto-antigen, as the weakly 
pathogenic T cells, which remained silent in the untreated hosts, were activated 
upon the instillation of exogenous auto-antigen. It is proposed here that the 
presentation of local auto-antigen by BBB-associated APCs provides stimuli that 
guide autoimmune T cells to the CNS destination and enable them to attack the 
target tissue. 
In addition, a theoretical, physicist approach was used for modeling T cell activation 
in the leptomeningeal space. Assuming that T cells have evolved to gain their 
activation signal in a way that is energetically optimal for them, two possible 
scenarios for T cell activation were compared. The first one assumes that, after 
finding an APC presenting the epitope of interest, the T cell will stop and interact with 
the APC until it becomes fully activated. The second model considers the possibility 
that a T cell can accumulate activation signals from different APCs while scanning 
them without stopping, until a certain threshold is exceeded and the T cell becomes 
activated. Using this approach, it is proposed that the T cells in EAE are more likely 
to become activated following the first scenario. However, in a more natural 
environment such as a lymph node, the second scenario could give them some 
advantages.
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ZUSAMMENFASSUNG 
Entzündliche Autoimmunerkrankungen des zentralen Nervensystems (ZNS) können 
durch T-Zellen ausgelöst werden, welche in das Gewebe einwandern und dort 
vielfältige Wechselwirkungen mit Komponenten der Blut-Hirn-Schranke (BBB), 
insbesondere Endothelzellen und perivaskulären Makrophagen, eingehen. Zur 
Aufklärung der genauen funktionellen Abläufe wurde in dieser Arbeit die Methode 
der intravitalen 2-Photonen-Mikroskopie eingesetzt. Hiermit konnten drei 
verschiedene Myelin-spezifische GFP-exprimierende T-Zelllinien untersucht werden, 
welche ein unterschiedliches Potential bei der Auslösung der Experimentellen 
Autoimmunen Enzephalomyelitis (EAE) besitzen. Die Mikroskopie konnte zeigen, 
dass alle T-Zelllinien unabhängig von ihrer Pathogenität in die Meningen einwandern 
konnten und dort gleichermaßen mit dem Endothel interagierten. Dabei war 
insbesondere die Migration der T-Zellen auf der interluminalen Seite der Blutgefäße, 
welche überwiegend gegen den Blutstrom verläuft, bei allen Zelllinien identisch. 
Nach der Extravasation unterschieden sich die Motilität der T-Zellen und ihre 
Interaktion mit perivaskulären Antigen-präsentierenden Zellen (APCs) jedoch 
grundlegend zwischen den T-Zelllinien. Während die hoch enzephalitogenen Zellen 
bei einer stark reduzierten Motilität stabile Kontakte mit APCs ausbildeten, waren die 
Wechselwirkungen zwischen APCs und den gering pathogenen Zellen kürzer. 
Zudem bewegten sich Letztere mit höherer Geschwindigkeit und waren nur 
geringfügig aktiviert. Die Applikation von Autoantigen durch lokale Injektion in die 
Meningen oder mittels Transfer von in vitro beladenen meningealen APCs führte zu 
einer Verlangsamung der gering enzephalitogenen T-Zellen. Die Dauer der Kontakte 
mit den APCs glich sich der von hoch pathogenen Zellen an. Nur durch exogenes 
Antigen konnten die gering enzephalitogenen Zellen aktiviert werden, welche 
daraufhin in das ZNS-Parenchym einwanderten und dort die klinischen Symptome 
der EAE auslösen konnten. Daraus kann geschlossen werden, dass die Stärke der 
Antigen-abhängigen Signale, welche die T-Zellen von den leptomeningealen APCs 
erhalten, für die Induktion der pathogenen Effektorfunktionen maßgeblich ist. 
Um die Motilität der enzephalitogenen T-Zellen und ihre Interaktionen mit APCs 
direkt miteinander korrelieren zu können, wurde eine verkürzte GFP-markierte 
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Version des nukleären Faktors aktivierter T-Zellen (NFAT-GFP) verwendet. Hiermit 
war es möglich die Aktivierung der Zellen direkt visuell darzustellen. Mittels 2-
Photonen-Mikroskopie konnte so gezeigt werden, dass die Zellen erst in den 
Leptomeningen aktiviert werden, jedoch noch nicht während der intraluminalen 
Migration. Darüber hinaus korrelierte die Aktivierung der Zellen mit reduzierter 
Motilität und intensivierten Kontakten mit den perivaskulären APCs, führte aber nicht 
notwendigerweise zu einem lang andauernden Arrest der T-Zellen. Der Import von 
NFAT in den Nukleus trat nur in hoch enzephalitogenen Zellen spontan auf, konnte 
jedoch bei den gering pathogenen T-Zellen durch die Zuführung von exogenem 
Autoantigen gezielt induziert werden. 
Aus diesen Beobachtungen kann geschlossen werden, dass die perivaskulären 
APCs in den Leptomeningen durch die Präsentation von Autoantigen selbst-reaktive 
T-Zellen aktivieren können und sie so zur weiteren Einwanderung in das ZNS und 
letztlich zur Schädigung des Nervengewebes befähigen. 
In einem weiteren Teil der Arbeit wurde ein theoretischer Ansatz entwickelt, um die 
T-Zell-Aktivierung in den Meningen mathematisch zu beschreiben. Hierbei wurde die 
Grundannahme gemacht, dass T-Zellen sich evolutionär so entwickelt haben, dass 
sie mit einem minimalen energetischen Aufwand aktiviert werden können. Es wurden 
in dem hier erarbeiteten Modell zwei Szenarien verglichen: Das erste Szenario 
nimmt an, dass die T-Zellen bereits durch eine einzelne APC bei einer längeren 
produktiven Interaktion aktiviert werden können. Im zweiten Fall wird postuliert, dass 
die T-Zellen für eine erfolgreiche Aktivierung die Signale von mehreren APCs 
akkumulieren müssen. Unter Verwendung dieses Modells konnte gezeigt werden, 
dass im ZNS die T-Zell-Aktivierung unter energetischen Aspekten idealerweise nach 
dem ersten Szenario ablaufen wird. In anderen anatomischen Umgebungen, wie 
etwa einem Lymphknoten, könnte die Aktivierung nach dem zweiten Szenario 
energetisch bevorzugt sein. 
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1 INTRODUCTION 
1.1 Multiple Sclerosis 
Multiple Sclerosis (MS) is a chronic autoimmune inflammatory disease in which 
myelin sheaths around axons of the brain and the spinal cord are damaged, 
ultimately resulting in neuronal death. Depending on the region in the Central 
Nervous System (CNS) where demyelination occurs, the disease symptoms are 
manifold, with patients having individual patterns of defects and a highly 
unpredictable disease course. For this reason responsiveness to available therapies 
is often uncertain (Compston and Coles, 2008; Gold et al., 2006). The disease 
affects 2.5 million people worldwide, mostly young adults (20–40 years of age), and 
is twice more frequent in in women than in men (Flachenecker and Stuke, 2008). 
MS can be classified in subtypes based on two criteria: 1) clinical course and 2) 
morphology of the CNS lesions. According to the heterogeneity of the clinical course, 
four different types of MS were described (Kieseier and Hartung, 2003). The most 
common type is a relapsing-remitting (RRMS) disease course, which is present in 
85% of MS patients, and is characterized by alternating periods of acute disease and 
recovery. In secondary-progressive MS (SPMS), disease symptoms are constantly 
worsening without occasional relapses, and 50% of patients with RRMS will 
eventually develop SPMS. A minority of patients develops primary-progressive MS 
(PPMS), where the disease is gradually progressing from the beginning, or 
progressive-relapsing MS (PRMS), where a progressive disease course is 
interrupted by acute relapses that may or may not include recovery. Four different 
MS subtypes were also defined on the basis of myelin protein loss, the geography of 
lesions, patterns of oligodendrocyte destruction, and the immunopathological 
evidence of complement activation (Lassmann et al., 2007). 
By current hypothesis on MS pathology, the immune system produces an 
inflammatory response against a tissue-specific self-antigen, which identity to-date 
remains unknown. In consequence, cells of the immune system attack the myelin 
sheaths, leading to axonal damage and ultimately neuronal death (Engelhardt and 
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Coisne, 2011). This view on MS pathogenesis is mostly established from animal 
models for MS. It is considered that self-reactive T cells, which exist in the healthy 
immune system, get primed e.g. via bystander activation or antigenic mimicry, 
become auto-aggressive and acquire the capacity to traverse the blood–brain barrier 
(BBB). Once in the CNS, they encounter locally presented CNS-antigen(s), and are 
reactivated. Subsequently, these T cells orchestrate a complex cascade involving 
recruitment of antibody producing plasma cells and peripheral macrophages, 
culminating in myelin and axon damage (Hohlfeld, 2009). Supporting this, cytotoxic 
and helper T lymphocytes targeted against CNS-specific antigen have been found in 
MS patients, and the presence of oligoclonal bands (OCB) has been used as 
diagnostic marker for MS. This underlines the unambiguous role of B-cells and 
secreted antibodies in disease development. However, even 50 years after discovery 
of OCB in MS, their specificity is still not identified. 
Etiology of MS remains unknown to this day; however many observations have been 
made, suggesting that both genetic susceptibility and environmental factors play a 
role. Twin studies showing that disease concordance in monozygotic twins is much 
higher than in dizygotic (25% vs. 2%) (Dyment et al., 1997), provide clear evidence 
for a genetic contribution to MS etiology. Recent Genome-wide association study 
(GNAS) showed a correlation between human leukocyte antigen (HLA) type I and II 
genes and susceptibility to MS, where some of them (HLA‐DR15, type II; HLA-A*03, 
type I) (De Jager et al., 2008) are shown to increase probability for disease, and 
others (HLA-C554 and DRB11*1, type II; HLA-A*02, type I) (Compston and Coles, 
2008; Fogdell-Hahn et al., 2000) appear to have a protective effect. GNAS also 
revealed associations outside of the HLA, in particular the genes for the IL-2 and 
IL-17 receptor (Sawcer, 2008). The fact that most of the risk alleles are linked to the 
immune system, stresses its importance in disease development. 
MS risk differs between geographical regions, with disease being rare in tropical 
areas (Africa and South America), but common in temperate regions (Northern 
Europe and Northern America) (McAlpine, 1956), an evidence that the environment 
plays an important role in the disease etiology. Multiple migration studies also 
contribute to proof of an environmental component. The results suggest, that people 
who migrate before adolescence acquire the incidence rates of the region to which 
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they have migrated (Alter et al., 1978; Alter et al., 1966; Alter et al., 1970; Dean and 
Elian, 1997; Detels et al., 1978; Hammond et al., 2000), while people migrating to a 
region after adolescence retain the incidence rate of the region from which they grew 
up (Gale and Martyn, 1995). A possible explanation for the geographic discrepancy 
can be a lack of vitamin D in Northern countries due to a reduced exposure to 
sunlight (Smolders et al., 2008), as well as alterations in nutrition between different 
regions (Schwarz and Leweling, 2005). It has also been suggested that exposure to 
viruses such as EBV (Serafini et al., 2007), can trigger the disease through 
mechanisms of molecular mimicry (Lünemann et al., 2007). However, direct 
evidence for this has been lacking to date. 
1.2 Experimental Autoimmune Encephalomyelitis (EAE) 
The Experimental Autoimmune Encephalomyelitis (EAE) is the most intensively 
studied animal model of human MS. It was first described in 1925 by Koritschoner 
and Schweinburg (Koritschoner and Schweinburg, 1925) when they demonstrated 
that immunization with human brain homogenate, leads to the development of MS-
like symptoms in rabbits. Today there are many EAE models available with diverse 
clinical outcome and pathology, determined by the strain and species used, sex, 
auto-antigen, its dose and route of administration (Krishnamoorthy and Wekerle, 
2009). None of these EAE models represents the entire variability of the human 
disease, but each of them rather reflects certain aspects of MS (Wekerle et al., 
1994). Studies on EAE models have provided great insight into the disease 
mechanisms, and enabled immense progress in developing new drug treatments for 
human MS. 
There are three common ways to induce EAE (Gold et al., 2006). Active 
immunization with CNS auto-antigen, emulsified with Complete Freund’s Adjuvant 
(CFA) is known as active EAE (aEAE). Alternatively EAE can be induced by the 
passive transfer of CNS auto-antigen-specific CD4+ T cells that have been in vitro 
cultured and selected for antigen of interest, and is referred to as - transfer EAE 
(tEAE). Both approaches result in a neurological disease that starts with the loss of 
tail tonus and is followed, from caudal to rostral, by limb weakness and paralysis. 
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These symptoms are associated with a strong inflammation in the CNS. The main 
difference between active and transfer EAE is in their kinetics, as the onset of tEAE 
is earlier compared to aEAE. The reason is that in aEAE, the T cells first need to get 
primed in lymph nodes, while in tEAE already primed T cells are injected. CNS auto-
antigens used for induction of both active and transfer EAE include myelin antigens 
such as oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and 
proteolipid protein (PLP), but also some non-myelin CNS antigens such as S100β, 
which is expressed primarily on astrocytes (Kojima et al., 1994). 
Over the past years spontaneous EAE models have been developed. They include 
single transgenic mouse models based on a MBP-specific TCR (Goverman et al., 
1993; Lafaille et al., 1994) developing classical EAE, as well as a MOG-specific TCR 
(TCRMOG) developing relapsing-remitting EAE (Pöllinger et al., 2009), or a double 
transgenic model with TCRMOG and IgHMOG, developing opticospinal EAE (Bettelli et 
al., 2006; Krishnamoorthy et al., 2006). The main advantage of these models is that 
the disease development depends on T cell - B cell cooperation, which 
mechanistically brings them closer to human MS. 
1.3 tEAE in rat 
Transfer EAE in rats can be induced by adoptive transfer of in vitro stimulated CD4+ 
CD8- CNS-specific T cell blasts (Ben-Nun et al., 1981). The greatest advantage of 
the transfer EAE model in the rat is its high predictability and reproducibility. The 
disease is monophasic, and does not start immediately upon T cell transfer, but 
following a disease free period of 3-4 days. The disease peaks 5-6 days after T cell 
transfer and ends with a complete recovery around day 10 post transfer (p.t.) (Figure 
1.1). 
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Figure 1.1 Clinical course of tEAE in Lewis rat. Body weight (line) and clinical symptoms (bars) 
following i.v. transfer of TMBP-GFP cells are depicted. Four different EAE phases can be distinguished: a 
disease-free prodromal period; developing clinical symptoms; disease maximum and recovery from 
paralytic disease (indicated by different background colors). Disease severity was scored as follows: 
0, no disease; 1, flaccid tail; 2, gait disturbance; 3, complete hind limb paralysis; 4, tetraparesis. 
The reason for delayed EAE onset is attributed to the specific immune situation of 
the brain (Hickey et al., 1991; Wekerle et al., 1986). The brain is considered to be an 
immune-privileged organ, due to the tight BBB, that restricts access of soluble 
molecules and cells, and therefore immune cells are rare. In addition, lymphatic 
vessels are sparse, and expression of factors needed for an efficient immune 
response, such as MHC and costimulatory molecules, is extremely low. By current 
hypothesis, encephalitogenic T cells overcome this obstacle by invading the brain in 
two waves. The first invasion occurs within hours after transfer, when very few 
activated “pioneer” T cell blasts can enter the brain and start to produce pro-
inflammatory cytokines, to create immune permissive milieu, and enable second 
massive invasion of antigen-specific T cells (Flügel et al., 2007). Prior to this second 
invasion of the CNS, the T cells acquire a “migratory phenotype” in the peripheral 
lymphoid organs such as spleen, up-regulating chemokine receptors and down-
regulating activation markers, (Flügel et al., 2001) and by this acquiring the capacity 
to migrate into the CNS. Upon arrival in the target organ, T cells are reactivated by 
local antigen presenting cells (APCs) presenting endogenous myelin antigen, 
(Bartholomäus et al., 2009; Kivisäkk et al., 2009), to produce abundant amounts of 
inflammatory cytokines. This recruits other non-specific immune cells such as 
INTRODUCTION 
 
10 
 
macrophages, which play a main role in causing the neurological disorder, by 
releasing toxic cytokines, which act on neurons and glial cells (Huitinga et al., 1990). 
Like in other EAE models, tEAE in rats can also result in different neurological 
disorders, depending on the genetics of the experimental animals and on the T cell 
antigen-specificity used for induction. For example, the Dark Agouti (DA) strain is 
highly susceptible to tEAE induced by MOG-specific T cells (Storch et al., 1998). 
However, in a different genetic background, the Lewis (LE) strain, MOG-specific 
T cells have only a very mild effect (Weissert et al., 1998). Nevertheless, T cells 
specific for MBP, another myelin antigen, induce a severe neurological disorder in 
the same strain (Swanborg and Amesse, 1971). Similar to human MS, this difference 
has been linked mainly to MHC gene region (Weissert et al., 1998), suggesting that 
T cell activation has crucial role for the disease development as shown by Kawakami 
and collages (Kawakami et al., 2004). 
1.4 Breakage of the BBB 
Brain-specific autoimmune T cells on their way to the CNS face a challenge of the 
BBB, which is a complicated composite of a central endothelial tube and two 
concentrically arranged basal laminas, in which pericytes and phagocytes are 
embedded (Sorokin, 2010). This barrier blocks most of the circulating blood 
components, but its impermeability is not absolute. Due to this, the T cells mediating 
EAE have developed an elaborate set of sequential interactions with different BBB 
components to access the brain tissue (Figure 1.2). 
INTRODUCTION 
 
11 
 
 
Figure 1.2. T cell invasion into the CNS. Schematic picture illustrating the invasion steps of TMBP-GFP 
cells in the CNS tissue. (Adopted from Bartholomäus et al., 2009) 
The first contact between encephalitogenic T cells and the BBB occurs on the 
luminal surface of the endothelial tube. The T cells attach to the intraluminal surface 
of leptomeningeal vessels, first roll along, and then continue to crawl on the 
endothelial cells, scanning for extravasation site. Both modes of motion differ in the 
molecules used for the endothelial contacts. While rolling occurs along the blood 
stream and involves transient interactions between selectins and glycoproteins 
(Piccio et al., 2002), crawling is preferably against direction of blood flow and 
depends on the binding of α4 and αL integrins (Bartholomäus et al., 2009). Blocking 
of these adhesion molecules interferes with tight attachment, completely washing 
crawling T cells away, and dramatically ameliorates clinical EAE. Indeed, 
Natalizumab, the therapeutic humanized α4 integrin blocking antibody is highly 
effective in reducing MS relapse rate (Lanzillo et al., 2012).  
After extravagating from the blood vessels, T cells continue their scan on the 
albuminal vascular surface, where they can encounter perivascular phagocytes, able 
to present foreign as well as local antigens (Bartholomäus et al., 2009; Kivisäkk et 
al., 2009), make serial contacts with them, and eventually become activated. These 
observations led to the hypothesis, that the presentation of auto-antigens by those 
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perivascular antigen presenting cells (APCs) provides immigrant T cells with the 
critical cues that direct them into the CNS parenchyma. However, due to technical 
limitations, direct visualization of functional intercellular interaction leading to T cell 
activation has been lacking to date. 
Strength of T cell reactivation determines infiltration rate and clinical outcome of the 
disease: in Lewis rat, for example, MBP-specific T cells are activated in the CNS by 
endogenous MBP, triggering classical acute EAE, which can be exacerbated by 
addition of exogenous MBP and following aggravated T cell activation (Odoardi et 
al., 2007a). On the other hand MOG-specific T cells display no activation, and hardly 
mediate any clinical defects (Kawakami et al., 2004). The reason for this is that T cell 
reactivation is accompanied by activation of the endothelium and loosening of the 
BBB, allowing further recruitment of immune cells. This massive immune cell 
infiltration into the CNS will eventually lead to a neurological disorder and the 
development of clinical symptoms. 
1.5 T cell activation 
In order to become activated, a T cell must engage in a productive interaction with 
an APC, leading to formation of an immunological synapse (IS) at the T cell-APC 
contact site. The IS is an highly organized structure, representing the simultaneous 
engagement of the TCR and costimulatory molecules on the T cell with the peptide-
MHC complex and costimulatory molecules on the APC. Resulting TCR stimulation 
triggers a signaling cascade, leading eventually to the transcription of activation 
relevant genes. 
1.5.1 T cell – APC contacts 
To get activated, T cells must first make series contacts with APCs, each of which 
provide opportunity for antigen recognition to occur. Despite a good fundamental 
understanding of T cell activation, the way individual T cell experience their 
encounter with APC has been unknown for a long time. Experiments done in vitro, 
supported the idea that antigen recognition by T cells induces cell-arrest and 
formation of long lasting contacts with the presenting cell (Donnadieu et al., 1994; 
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Dustin et al., 1997; Negulescu et al., 1996). However, this was challenged by other 
in vitro finding showing that naive cells can become activated after establishing 
multiple short interactions (duration less than 10 min) with antigen-bearing DCs 
(Gunzer et al., 2000). 
With development of two-photon laser scanning microscopy, it became possible for 
the first time to investigate the dynamic T cell – APC interactions in vivo. But instead 
of solving the controversy by providing a simple answer, it in fact documented a high 
diversity in T cell – APC contact dynamics (Bousso, 2008). Most experiments have 
so far been done in lymph nodes, the main environment where T cells are getting 
primed. 
In the absence of the cognate antigen, T cells make serial transient contacts with 
DCs (duration of 3-5 min), resulting in infrequent Ca2+ signals (an early indicator of 
the activation stimulus) during these interactions (Asperti-Boursin et al., 2007; Wei et 
al., 2007).These contacts might still be functionally important for providing “tonic 
signals”, as naive T cells lose their motility in the lymph node if they are prevented 
from engaging MHCII molecules on the APC surface (Fischer et al., 2007). 
In the presence of abundant amount of antigen that induces robust T cell activation, 
T cells are observed to make stable, long lasting contacts with DCs that often 
exceed imaging period of 30-60 min. It has been shown, that 6 h of stable interaction 
with DCs is needed to induce a clonal expansion of naive CD4+ T cells (Celli et al., 
2007), but what kind of signaling the T cells receive during this time and how their 
activation is affected, remains still unknown. 
Apart from stable T cell – DC interactions, in presence of antigen T cells can be also 
engaged in contacts with DCs that are relatively short and hardly distinguishable 
from contacts with DCs without antigen to present. One reason could be that these 
contacts are simply unproductive, due to limiting amount of peptide-MHC complexes 
on APC surface, which T cells are then missing during the contact. However, there 
are data indicating that these interactions can also result in activation of both CD4+ 
as well as CD8+ T cells without inducing their arrest (Moreau et al., 2012; Skokos et 
al., 2007). Discriminating productive from nonproductive T cell – APC interactions 
remains a challenge for future studies. 
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1.5.2 Immunological synapse 
Recognition of peptide-MHC complexes by the TCR results in a specialized 
membrane contact between T cell and APC, termed immunological synapse (IS). 
The IS is considered to have three functional layers (Figure 1.3A), based on receptor 
interactions, signal transduction and cytoskeletal transport (Dustin and Depoil, 2011). 
The receptor layer is defined by supramolecular activation complexes (SMACs), 
which are composed by centrally located TCR/CD3-MHC/peptide ligand pairs, along 
with costimulatory molecules such as CD28 and CTLA4. Additionally a ring of 
surrounding adhesion interaction partners, such as LFA1-ICAM1, ensures a tight 
T cell-APC interaction (Fig 1.3B). 
 
Figure 1.3. Structure of the Immunological Synapse. (A) Three layers of the Immunological 
Synapse (IS) on the T cell side. The receptor layer contains the TCR–CD3 complex, CD4 or CD8, 
CD28 and LFA1. The signaling layer includes LCK, ZAP70, ITK, PLCγ and PKCθ. The cytoskeletal 
layer contains F-actin, talin, paxillin and vinculin. (B) Supramolecular activation clusters (SMACs) of 
an IS, as seen looking down on a T cell. The TCR-rich central SMAC is shown in red, the CD28-rich 
periphery is depicted in green and the LFA1-rich peripheral SMAC is displayed in blue color. (Adopted 
from Dustin and Depoil, 2011) 
Upon antigen recognition, stimulation of TCR induces series of intracellular signaling 
cascades. As the TCR has no intrinsic catalytic activity itself, it forms a complex with 
CD3, which itself has six subunits with long cytoplasmic domains, containing 
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immunoreceptor tyrosine-based activation motifs (ITAMs). ITAMs are 
phosphorylated by SRC family kinases LCK, and recruit ZAP70, a non-receptor 
tyrosine kinase, via a relatively high affinity interaction by binding to the tandem SH2-
domains of ZAP-70. This binding leads to activation of ZAP-70, which subsequently 
phosphorylates a number of signaling proteins, including the linker for the activation 
of T cells (LAT). This leads to recruitment of the IL-2 inducible T cell kinase (ITK) and 
activation of phospholipase C γ (PLCγ). 
TCR activation is also regulated by various costimulatory receptors such as CD28 
and CD45. CD28 provides an essential co-stimulatory signal during T cell activation, 
which augments the IL-2 production, increases T cell proliferation and prevents the 
induction of anergy and cell death. Once ligated by B7 on the surface of the APCs, 
CD28 provides the T cell with an initial adhesion, bringing the T cell and APC 
membranes closer together. CD45 regulates TCR signaling by modulating the 
phosphorylation state of tyrosine kinases like Lck, and antagonizing inhibitory 
proteins, thereby favoring T cell activation (Dustin and Depoil, 2011). 
The cytoskeletal layer is assembled by three filament forming proteins: actin, myosin 
II and tubulin. Integrin-dependent adhesion requires F-actin, and partially depends 
on myosin II. Integrins are linked to F-actin through proteins such as talin and 
vinculin (Figure 1.3A). TCR engagement induces actin polymerization with 
generation of forceful protrusions, and by recent finding, TCR can act as a 
mechanotransducer, meaning that it can generate signal transduction in response to 
forces (Dustin and Depoil, 2011). 
1.5.3 Signal transduction in lymphocyte activation 
Antigen binding to TCR leads, as mentioned, via activation of several layers of 
protein kinases, to activation of PLCγ which hydrolyses phosphatidylinositol-3,4-
bisphosphate to diacylglycerol and inositol‑1,4,5-trisphosphate (IP3). IP3 then binds 
to the IP3 receptor, which is a Ca2+-permeable ion channel, and Ca2+ is released 
from intracellular Ca2+ stores in the endoplasmic reticulum (ER). Ca2+ released from 
the ER results only in a moderate and transient increase of the intracellular Ca2+ 
concentration, due to the small volume of the ER. Importantly, the decrease of the 
Ca2+ concentration in the ER triggers the activation of a store-operated calcium entry 
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(SOCE) pathway, resulting in the opening of store-operated Ca2+ channels in the 
plasma membrane. In lymphocytes, the CRAC channel is the best described and the 
main store-operated Ca2+ channel. Ca2+ influx via CRAC channels results in a 
sustained Ca2+ signal and increased levels of intracellular Ca2+ are maintained 
(Feske, 2007). Ca2+ binds calmodulin, which in turn activates the calmodulin-
dependent phosphatase calcineurin. Activated calcineurin dephosphorylates Nuclear 
Factor of Activated T cells (NFAT), which leads to its nuclear translocation and the 
induction of NFAT-mediated gene transcription (Figure 1.4) (Macian, 2005). 
 
Figure 1.4. Signaling pathway connecting store-operated Ca
2+ 
entry with NFAT-dependent gene 
transcription in T cells. T cell receptors assemble into signaling complexes that contain scaffold 
proteins such as LAT, tyrosine kinases such as Itk, and phospholipase C γ (PLCγ). IP3 produced by 
PLCγ binds to receptors in the ER membrane, causing the release of Ca
2+
 from the ER. The depletion 
of ER Ca
2+
 stores, causes opening of CRAC channels. The resulting increase of intracellular Ca
2+
 
causes the universal and abundant cytoplasmic Ca
2+
 sensor calmodulin (CaM) to bind to various 
channels and enzymes and modulate their activity. Among the targets of CaM is the phosphatase 
calcineurin, which dephosphorylates NFAT and causes its nuclear translocation, thus activating 
NFAT-dependent transcription (Adopted and modified from Hogan et al., 2010). 
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1.6 NFAT proteins 
Initially, NFAT was identified as an inducible nuclear factor that could bind 
interleukin-2 (IL-2) promoter in activated T cells. However, it soon became clear that 
the expression of NFAT proteins was not limited to T cells, as at least one NFAT 
family member is expressed by almost every cell type. The NFAT family consists of 
five members (NFAT1-5), four of which are regulated by calcium signaling and have 
a highly conserved DNA-binding domain. Three of calcium regulated proteins (NFAT 
1, 2 and 4) are expressed by T cells. Different NFAT proteins having selective roles 
in T cell differentiation has been a controversial idea. Current data suggest however, 
that NFAT1 and NFAT2 are functionally redundant (Avni et al., 2002), while NFAT4 
seems to have preferential role in development of CD4+ and CD8+ T cells (Oukka et 
al., 1998). 
 
Figure 1.5. Scheme of NFAT and its domains. This schematic representation illustrates the location 
of the transactivation, regulatory, DNA-binding and carboxy (C)-terminal domains of NFAT1. 
Regulatory motifs in the NFAT homology region (NHR) and motives in REL-homology domain (RHR) 
are highly conserved among the calcium–calcineurin-regulated NFAT proteins (NFAT1–NFAT4). NHR 
includes the calcineurin-docking site, the nuclear localization signal (NLS), the serine-rich regions 
(SRRs) and the SPXX-repeat motifs (SPs), where X denotes any amino acid. An inducible 
phosphorylation site has also been described in the N-terminal transactivation domain (TAD) of 
NFAT1. The phosphoserines that are targeted by calcineurin dephosphorylation are located in the 
SP2, SP3 and SRR1 motifs. These serines are phosphorylated in the cytosol by maintenance kinases 
and in the nucleus by export kinases. (Adopted from Macian, 2005). 
Each NFAT protein has two or more alternatively spliced forms. Splicing results in 
variations of the amino- (N) and carboxyl- (C) termini, with the core region being 
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conserved. The conserved core region of NFAT proteins consists of two tandem 
domains: a regulatory domain, which is also known as the NFAT-homology region 
(NHR); and the REL-homology domain (RHR), which binds DNA (Figure 1.5). The 
NHR contains many serine residues that are phosphorylated in resting T cells. It also 
includes the docking sites for calcineurin and the NFAT kinases, which regulate the 
activation of NFAT proteins by determining the phosphorylation status of the serines. 
All but one of the 14 phosphorylation sites, which have been mapped in NFAT1 and 
are conserved in all calcineurin-regulated NFAT proteins, are dephosphorylated by 
calcineurin. Dephosphorylation of the serine residues in these motifs leads to 
exposure of the NFAT1 nuclear localization signal and its nuclear import. Several 
kinases have been reported to phosphorylate NFAT proteins and control their 
nuclear shuttling, including glycogen-synthase kinase 3, casein kinase 1, p38 and 
JUN N-terminal kinase (Macian, 2005). The present data point to a complex model, 
in which different kinases phosphorylate the various serine-rich motifs in NFAT 
proteins. It is also necessary to distinguish between maintenance kinases, which act 
in the cytosol to keep NFAT proteins in a fully phosphorylated state and prevent their 
translocation into the nucleus in resting cells, and export kinases, which 
rephosphorylate NFAT in the nucleus and promote its nuclear export; thereby 
stopping NFAT-mediated transcription after T cell stimulation is withdrawn. 
The importance of NFAT proteins in T cell activation is highlighted by genetic data. In 
two human families, failure to activate NFAT proteins because of a defect in store-
operated calcium entry was associated with severe immunodeficiency (Feske et al., 
2000). In mice, deficiency in both NFAT1 and NFAT2 in T cells results in grossly 
impaired production of many cytokines, including IL-2, IL-4, IL-10, IFN-γ, 
granulocyte/macrophage colony stimulating factor (GM-CSF) and TNFα. IL-5 
expression is also notably diminished, as well as the expression of CD40L and 
CD95L (Peng et al., 2001), which confirms that the activation of NFAT proteins is 
essential for T cells to carry out many of their effector functions. The analysis of gene 
expression using DNA microarrays has also clearly shown that the activation-
induced expression of most genes in T cells is blocked by calcineurin inhibitors 
(Feske et al., 2001; Macian et al., 2002). 
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Given the important role of NFAT proteins in the control of T cell activation, NFAT 
has always been considered to be an optimal target for therapeutic approaches that 
are aimed at regulating immune responses. Inhibitors of calcineurin, such as 
Ciclosporin A (CsA) and FK506, have been extensively used as immunosuppressive 
agents to improve graft survival and to treat autoimmune diseases (Macian, 2005) 
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OBJECTIVES 
In experimental models of MS, clinical patterns can be determined by both, 
properties of myelin-specific auto-reactive effector T cells, and factors in the target 
tissue milieu (Ransohoff, 2009). These factors control the nature of interactions 
between effector cells and target tissue, from the earliest stages of the immune cell 
arrival to the terminal immune attack in the target tissue. Within this pathogenic 
cascade, entry of autoimmune effector T cells into the CNS target tissue plays a 
critical role in dictating the clinical outcome. 
The present work was designed to unravel the role of locally presented neural auto-
antigen in the formation of EAE lesions. We used three different T cell lines, which 
are indistinguishable in their general properties, but mediate EAE of different clinical 
intensity (Kawakami et al., 2004). By using in vivo two-photon imaging, we compared 
T cell migration patterns and local antigen presentation events between classical 
MBP-specific T cells of the Lewis rat, MOG-specific T cells of Dark Agouti rats (both 
highly encephalitogenic), and MOG-specific T cells of Lewis rats (weakly 
encephalitogenic). 
To study the functional aspect of interactions between auto-reactive T cells with 
different encephalitogenic potential, and structures of the vascular BBB, a 
fluorescent derivative of truncated NFAT (∆NFAT-GFP) was introduced as an a 
indicator of in vivo and in situ T cell activation. Due to the lack of suitable markers so 
far, autoimmune activation events were never shown formally in vivo before, and this 
drawback should be overcome by this project. 
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2 MATERIAL AND METHODS 
2.1 Material 
2.1.1 Reagents and Buffers  
Medium Specified amount  
DMEM 13.4 g/L 
3.7 g/L 
DMEM powder 
NaHCO3 
Freezing medium 50 % Vol. 
40 % Vol. 
10 % Vol. 
Horse serum (inactivated) 
TCM 
DMSO 
EH 97.5 % Vol. 
2.5 % Vol. 
DMEM 
HEPES solution, 1M 
Lysis buffer 
 
150 mM 
1 mM 
0.1 mM 
NH4Cl 
KHCO3 
Na2EDTA 
Restimulation medium (RM) 99 % Vol. 
1 % Vol. 
TCM 
Rat serum 
TCGF 80 % Vol. 
10 % Vol. 
10 % Vol. 
TCM 
Horse serum (inactivated) 
Supernatant from ConA 
stimulated mouse 
splenocytes 
TCM ad 1 L 
2 mM 
100 IU/ml, 100 µg/ml 
3.6 g/l 
1 mM 
10 ml/L 
4 μl/L 
DMEM 
L-Glutamine 
Penicillin/Streptomycin 
Asparagine 
Sodium-Pyruvate 
Non-essential amino acids 
2-Mercaptoethanol 
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Medium Specified amount  
TCM + FCS 90% Vol. 
10% Vol. 
TCM 
Fetal calf serum 
(inactivated) 
PBS (pH 7.4) 12 mM 
137 mM 
2.7 mM 
Na2HPO4 / NaH2PO4 
NaCl 
KCl 
FACS buffer  95 % Vol. 
5 % Vol. 
0.05 % 
PBS 
Rat serum 
NaN3 
CNS density gradient 
reagent 
10.8 mL 
10 mL 
Isotonic Percoll (1.124g/mL) 
Underlay Percoll 
(1.077g/mL) 
Blood lymphocyte gradient 
reagent 
100 μL 
0.63 mL for 5 mL blood 
Heparin (5000U/mL) 
Optiprep 
Ca2+ imaging buffer (pH 7.4) 140 mM 
5 mM 
1 mM 
1 mM 
1 mM 
5.5 mM 
20 mM 
NaCl 
KCl 
MgSO4 * 7 H2O 
CaCl2  
NaH2PO4 * H2O 
Glucose 
HEPES 
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2.1.2 Antibodies 
Antibody  
(clone, isotype) 
Host and specificity 
company 
Applications 
isotope control 
(MOPC31c, IgG1) 
mouse  
Sigma 
Flow cytometry, 
primary antibody 
CD4  
(W3/25, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
αβ TCR 
(R73, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
CD134  
(OX40) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
CD25  
(OX39, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
IFNγ  
(DB-1, IgG1) 
Mouse anti-rat 
eBiosciences 
Flow cytometry, 
primary antibody 
IL-17  
(TC11-18H10, IgG1) 
PE-conjugated rat anti-mouse 
BD 
Flow cytometry, 
primary antibody 
integrin αL  
(WT.1, IgG2a) 
mouse anti-rat 
provided by Dr. Masayuki Miyasaka 
Flow cytometry, 
primary antibody 
integrin α4  
(TA-2, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
ICAM-1 
(1A29, IgG1) 
mouse anti-rat 
provided by Dr. Masayuki Miyasaka 
Flow cytometry, 
primary antibody 
VCAM-1 
(MR106, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
CD62L 
(HRL2, IgG) 
Armenian hamster anti-rat 
provided by Dr. Masayuki Miyasaka 
Flow cytometry, 
primary antibody 
MHCII 
(OX6, IgG1) 
mouse anti-rat 
Serotec 
Flow cytometry, 
primary antibody 
APC IgG Goat anti-mouse 
Jackson Laboratory 
Flow cytometry, 
secondary antibody 
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Antibody  
(clone, isotype) 
Host and specificity 
company 
Applications 
PerCP IgG Rabbit anti-mouse 
Santa Cruz 
Flow cytometry, 
secondary antibody 
APC IgG Goat anti-armenian hamster 
Jackson Laboratory 
Flow cytometry, 
secondary antibody 
laminin α1 
(polyclonal) 
rabbit anti-rat serum 
provided by Dr. Takako Sasaki 
Histology 
primary antibody 
CD43 
(W3/13, IgG2b) 
Mouse anti-rat 
Serotec 
Histology 
primary antibody 
Cy3 IgG Goat anti-rabbit  
Jackson Laboratory 
Histology 
secondary antibody 
2.1.3 Antigens 
MBP was prepared from guinea pig brain homogenates as reported (Campbell et al., 
1973), and recombinant MOG (amino acids 1-120) was produced as described 
(Adelmann et al., 1995). 
2.1.4 Animals 
Lewis rats were obtained from the animal facility at the Max Planck Institute of 
Biochemistry. Dark Agouti rats were purchased from Harlan. LE and DA rats were 
interbred to obtain the F1 generation. All animals were kept and bred in the animal 
facility at the Max Planck Institute of Neurobiology and all experiments were 
conducted according to Bavarian state regulations for animal experimentation and 
approved by the appropriate authorities.  
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2.2 Methods 
2.2.1 Cell culture 
Cultivation of cell lines. T cell lines were cultivated in fully complemented DMEM 
medium in standard cell culture-treated plastic dishes (BD) in a humidified incubator 
(Heraeus) at 37°C and 10%CO2, respectively. Cells growing in suspension were 
harvested by repeatable pipetting, and adherent cells were treated with Trypsin-
EDTA (PAA Laboratories) for 3-5 min at 37°C. Cell densities were determined using 
a Neubauer hemocytometer (Neubauer). Cultures were kept subconfluent by regular 
dilution with fresh medium. Cells were pelleted by centrifugation at 250 rcf for 7 min 
at 4°C. 
Freezing and thawing of cell stocks. For preparation of long-term stocks, 20-30×106 
cells were harvested and resuspended in 1.5 mL of Freezing medium. Stocks were 
frozen in a dedicated Freezing Container (Thermo Fisher Scientific) at -80°C and 
subsequently stored in liquid nitrogen. For thawing, stocks were transferred to 37°C 
and washed once with 10 ml of EH to remove DMSO, before resuspension in 10 ml 
of warm medium. 
Generation of retrovirally transduced, antigen-specific T cell lines. Antigen-specific 
T cells were generated using the method of Flügel et al. (Flügel et al., 1999). Rats 
were immunized by subcutaneous injection of antigen (100 μg), emulsified in 
complete freunds adjuvant (CFA, Difco) containing Mycobacterium tuberculosis 
strain H37RA (4 mg/mL). Cells from the draining lymph nodes were isolated 10 days 
after immunization and co-cultured with GP+E-86 cells (2×105 of T cells with 1.5×104 
GP+E cells per well, in 96 well round-bottom plate), which were transfected to 
produce a GFP gene-coding retrovirus. Alternatively, GP+E-86 cells transfected with 
pMSCV-∆NFAT-GFP (aa 1-460 of mouse NFAT1) were used and cultured with a 
modified limiting dilution method. The T cells were positively selected by specific 
antigen stimulation (10 μg/mL), and negatively using an antibiotic resistance gene 
included in the retroviral vector. During the first two days, T cells were stimulated 
with their specific antigen in RM and afterwards IL-2 conditioned medium (TCGF) 
was added for expanding and maintaining selected cells until next stimulation. For 
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the following restimulation, T lymphocytes were incubated with irradiated (5000 rad) 
syngeneic thymocytes in the presence of antigen. At least three rounds of stimulation 
with the antigen, followed by expansion in the conditional medium were completed 
before the cells were used for the experiments. 
In vitro T cell proliferation assays. To evaluate the specificity of the established T cell 
lines for their respective antigen, in vitro proliferation assays were performed. 2×104 
T cells were cultured with 1×106 irradiated thymocytes in 100 μl of RM in a 96-well 
flat-bottomed plate for 48 h. Series of diluted antigens were used. Then, 3H-
thymidine was added to the culture and the plate was incubated for an additional 
16 h. 3H uptake was measured using a β-counter (Coulter). In some experiments, 
meningeal APCs, prepared as described (Bartholomäus et al., 2009), were used. 
Briefly, CNS meninges were dissected mechanically and homogenized. Then 106 
meningeal cells were co-cultured with 104 antigen-specific T cells. For some 
experiments meningeal APCs were pretreated with exogenous antigens (10 μg/ml 
for 1 h) and co-cultured with T cells. Production of IFNγ was examined by flow 
cytometry 48 h after co-culturing. 
2.2.2 Flow cytometric analysis (FACS) 
Quantification of cell numbers. At the indicated time points, animals were sacrificed 
by CO2. Spleen, CNS meninges and parenchyma were isolated, homogenized and 
suspended in EH, before used for further analysis. For cell quantifications, defined 
amounts of the cell suspension were mixed with a defined number of fluorochrome 
conjugated micro-beads (BD) and analyzed by FACSort (BD). Values are shown as 
cells per gram of organ. 
Surface staining. For the T cell surface marker staining, additional purifications were 
performed. Cells from the spleen were treated with lysis solution to remove 
erythrocytes, while T cells from the CNS parenchyma were purified by density 
gradient centrifugation (Percoll, GE Healthcare). Thereafter 1×106 cells per staining 
were used. To prevent nonspecific antibody binding, cells were incubated with FACS 
buffer in a 96-well plate for 10 min on ice. Subsequently, cells were incubated with 
the primary antibody (1 μg/sample) for 30 min on ice. After washing twice with FACS 
buffer, cells were incubated with fluorescently labeled secondary antibody (diluted 
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1:200 in FACS buffer) for 30 min on ice. Finally, the cells were washed once with 
FACS buffer and once with PBS. 
Intracellular staining. For intracellular stainings, cells were fixed in 2 % PFA for 
20 min followed by washing in PBS. Permeabilization was carried out using BD 
Perm/Wash buffer during incubation on ice for 15 min. All further steps were 
conducted in BD Perm/Wash buffer. The primary antibody for IFNγ (diluted 1:200) 
was added and incubated on ice for 30-60 min. After three washings with BD 
Perm/Wash, the secondary antibody (1:200 dilution) along with PE-IL-17 (1:400 
dilution) antibody were added and incubated for 90 min on ice followed by one 
washing with BD Perm/Wash, one with PBS and final resuspension in PBS. 
Stained cells were measured using a FACSCalibur flow cytometer (BD) and the data 
were analyzed by FlowJo software (Tree Star). 
2.2.3 Histology 
Organs from PFA-perfused rats were fixed in 4%PFA in PBS for 24 h and immerged 
in 40% sucrose. Tissues were embedded in Tissue-Tek O.C.T. Compound (Sakura), 
and 10 μm sections were cut on a CM3050 S Cryocutter (Leica). 
Tissue sections were thawed, fixed in 4%PFA for 20 min, and blocked with 5% Rat 
serum in PBS for 1 h at room temperature. This buffer was used for all further steps. 
Incubation with primary antibody (dilution 1:200) was done for 1 h at room 
temperature or at 4°C overnight, and with secondary (Cy3-conjugated anti-rabbit Ig 
dilution 1:500) for 1-3 h at room temperature. Three washings for 10 min were done 
in between. 
In vitro cultured resting TMBP-NFAT-GFP cells were labeled with PKH26 red fluorescent 
cell linker kit for general cell membrane labeling (Sigma-Aldrich). Part of the cells 
was treated with ionomycin (1 μM) for 3 min, and then stimulated and non-stimulated 
cells were incubated on collagen coated glass slides for 15 min to immobilize. Cells 
were fixed in 4%PFA and stained with DAPI (5 μg/ml) for 10 min. 
All slides were then left to dry and embedded in anti-fading mounting medium 
(Dianova). 
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All images were acquired on an inverted SP2 confocal microscope (Leica) equipped 
with a 20x objective lens (N.A: 0.7) or 40x oil immersion lens (N.A: 1.25) (both from 
Leica). 
2.2.4 Animal experiments 
Adoptive transfer EAE. Transfer EAE was induced by intravenous injection of 
5-10×106 encephalitogenic T cell blasts in to 8-12 weeks old animals. The animals 
were monitored for weight loss and clinical symptoms daily. Clinical evaluation was 
done by grading clinical scores as follows: 0.5, loss of tail tonus; 1, tail paralysis; 2, 
gait disturbance; 3, hind-limb paralysis; 4, tetraparesis; 5, death. 
Intrathecal injection. Animals were anesthetized by intramuscular injection of 
fentanyl/midazolam/medetomidin (5 µg/kg, 2 mg/kg and 150 µg/kg, respectively) and 
mounted in a stereotactic device. For labeling of meningeal APCs, 6 μg of Texas 
Red or tetramethylrhodamine conjugated dextran (molecular size: 70 kDa or 2 MDa 
respectively from Molecular Probes) was injected into the cisterna magna between 
C1 and C2 using a 27G needle (BD). For meningeal APC-pulsing, meningeal APCs 
were prepared from naive Lewis rats by mechanical homogenization. Cells were 
then incubated with antigen (10 μg/ml) in RM for 1 h at 37°C. Finally, cells were 
washed three times and then injected intrathecally. In some experiments, local APCs 
were visualized by intrathecal injection of DQ-MOG (custom synthesis by Molecular 
Probes). 1 μg of DQ-MOG was injected into anesthetized animals 2 h before 
imaging. For inducing inflammation in the leptomeninges, 30 ng LPS were injected. 
Splenocyte retransfer and SNARF-1 labeling. The “migratory” encephalitogenic 
T cells were prepared from host spleens 3 days after transfer. Erythrocytes were 
removed from the suspensions by osmotic lysis and the macrophages by adhesion 
on culture dishes by incubating for 1 h at 37°C. Prior to SNARF-1 labeling, 
splenocytes were enriched for CD4+ T cells using the MagCellect Rat CD4+ T cell 
Isolation Kit (R&D Systems). On average, 20-30% of the T cells were GFP/ΔNFAT-
GFP expressing cells. T cells were labeled with SNARF-1 (Molecular Probes) by 
incubating for 15 min at the concentration of 1.25 μM. SNARF-1 labeling results in a 
strong signal in the nucleus, whereas cytoplasm staining is often weaker. 
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2.2.5 Fluorescent video-microscopy 
Resting in vitro TMBP-NFAT-GFP cells were resuspended in buffer for Ca
2+ imaging and 
incubated in a μ-slide I 0.4 collagen coated microscopy chamber (ibidi). T cells were 
stimulated by 1 μM ionomycin during image acquisition, and imaging was continued 
for 15 min after stimulation. Cells were then collected, washed from ionomycin, 
plated again in new Microscopy chamber, and imaged for another 2-3 h. Images 
were acquired every 30 s. Time-lapse recordings were performed using an inverted 
Axiovert 200 M microscope, equipped with a 40x oil immersion objective (N.A. 1.3, 
Zeiss). Images were acquired by using a Coolsnap-HQ camera (Photometrics, 
Roper Scientific) and processed by MetaMorph software (Molecular Devices). 
2.2.6 In vivo two-photon microscopy 
Image acquisition. Time-lapse two-photon laser-scanning microscopy was performed 
using a SP2 confocal microscope (Leica) equipped with a 10 W Millenia/Tsunami 
laser (Newport Spectra Physics). Excitation wavelength was tuned to 880 nm and 
routed through a 20x water-immersion objective (N.A. 0.95, Olympus) or 25x water-
immersion objective (N.A. 0.95, Leica). Imaging was done with 1x or 2x zoom and 
30-50 μm z-stacks were acquired with 3-4 μm step size. Acquisition rate was 
25.219 s time interval, with images averaged twice. Fluorescent signals were 
detected using non-descanned photomultiplier tube detectors (Hamamatsu) 
equipped with 440/40 nm (detection of second harmonic), 525/50 nm (GFP), 
579/34 nm (tetramethylrhodamine dextran), 630/69 nm (Texas Red dextran and 
SNARF), and 685/40 nm (SNARF) band-pass filters (Semrock). 
Animal preparation. Animals were anesthetized by intramuscular injection of 
fentanyl/midazolam/medetomidin (5 µg/kg, 2 mg/kg and 150 µg/kg, respectively), 
orotracheally intubated, and ventilated with 2% isoflurane. Animals were placed on a 
custom-made microscope stage and the body temperature was regulated by a 
heated pad and thermo-sensor (37.5°C). Electrocardiograms were recorded and 
physiological parameters, such as concentrations of inspiratory and expiratory 
gases, and ventilation pressure were constantly monitored during imaging. 
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Spinal cord imaging. For spinal cord imaging a spinal cord window was prepared at 
level Th12/L1. After midline skin incision, the paravertebral musculature was 
detached from the spine and laminectomy on one spine disc was performed using a 
dental drill (FOREDOM). For reducing artifacts caused by heart beats and breathing 
of the animal, the laminectomized spine disc along with two neighboring discs was 
fixed using a custom made fixation mounted on the stage (Figure 2.1). Around the 
imaging window, an agarose ring was mounted, retaining the buffer in which water 
objective was embedded. Blood vessels and CNS meningeal APCs were visualized 
by intravenously and intrathecally injected fluorescent dextran conjugates. 
 
Figure 2.1. Fixation and stage for intravital microscopy of the spinal cord. (A) Rat prepared for 
spinal cord imaging. In the middle, the imaging window is opened and the spine is stabilized using a 
custom-made fixation. (B) Stage for intravital microscopy. Metal plate is heated and temperature 
regulated with a thermo-sensor on the left. ECG pads and a tube for the intratracheal intubation are 
depicted on the right. Fixation is mounted on the stage and its position can be adjusted in all 
dimensions. (Adopted from Bartholomäus, 2011). 
Spleen imaging. For spleen imaging, a skin incision was made and the spleen was 
gently pulled out of the animal, taking care that its blood connection is not disrupted. 
The organ was placed on a custom-made stage with an opening for the blood 
vessels, that was mounded as close to the animal as possible to reduce tension on 
the vessels. The spleen was embedded in warmed buffer and pressed slightly by a 
glass bottom culture dish for stabilization. 
Local injections into the imaging window. For local injections a microcapillary (tip 
diameter of 13 μm, Biomedical Instruments) was used, and hold by a micro-
manipulator (Luigs & Neumann). The capillary was pushed through the arachnoidea 
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through a hole cut by a high-energy two-photon laser. For the injection, the 
microcapillary was filled with a solution of 10 μg/ml of protein and 0.2 μg/ml 
tetramethylrhodamine dextran. A volume of 3-4 μl of this solution was injected. 
Image analysis. Time-lapse images were acquired using Leica LCS software (Leica), 
and subsequently processed and analyzed by ImageJ (NIH). To obtain two-
dimensional movies, a Gaussian blur filter was applied, the contrast was adjusted by 
liner rescaling, and maximum intensity z-projections were made. In some videos the 
noise was removed additionally using a Median filter. The position of T cells in the 
three-dimensional space was analyzed using Imaris software (Bitplane). For 
analyzing perivascular localization, T cells located further than 10 μm (thickness of 
endothelial cell plus attached T cell) from the blood vessels in the maximum 
projection were considered as detached and then correlated with the total cell 
number. The instantaneous T cell velocity was calculated by combining the cell 
coordinates with the time interval of imaging. Trajectory lines were drawn based on 
the coordinate information obtained. The calculation of the mean square 
displacement (MSD) was done for a 10 min time interval and only the cells present 
for the entire period of time were considered (Beltman et al., 2009). Cells were 
considered to be stationary if their displacement did not exceed 10 µm in 10 min. 
The T cell/APC contacts were analyzed manually, and all of the physical interactions 
between the T cells and labeled meningeal APCs in the three-dimensional volume 
were defined as contacts. The meandering index was calculated 
as                                   ⁄ . 
2.2.7 Statistical analysis 
The statistical evaluation was performed using Prism software (GraphPad). p<0.05 
was considered significant. n.s.: not significant. Test used, as well as the resulting p 
value is specified for each experiment separately in the figure legends. 
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3 RESULTS 
3.1 Infiltration of leptomeninges and parenchyma 
In this study, the early interactions of myelin-specific autoimmune T cells with target 
structures in the CNS were examined. Three types of GFP-labeled CD4+ T cell lines, 
distinguished by their encephalitogenic potential (Kawakami et al., 2004) were 
investigated: MBP-specific T cells from Lewis rats (TLE-MBP) and MOG-specific T cells 
from DA rats (TDA-MOG) were highly aggressive and induced a severe neurological 
disorder (EAEhi), while MOG-specific T cells from Lewis rats (TLE-MOG) hardly induced 
any symptoms (EAElo) (Figure 3.1.1). 
 
Figure 3.1.1 Representative clinical EAE course induced by GFP labeled TLE-MOG, TDA-MOG, and 
TLE-MBP cells. Lines depict the body weight (day 0 set to 100%, left y-axis) and bars indicate clinical 
scores (right y-axis). Data of three animals per group were averaged and representative data of at 
least three independent experiments are shown. 
However, all T cell lines were highly specific against their cognate antigen, and 
secreted TNFα, IL-10, MCP-1 and MIP-1 at comparable levels, but did not produce 
IL-4 (Kawakami et al., 2004). Additionally, their intracellular production of IFNγ/IL-17 
was very similar (Figure 3.1.2A), and expression of surface molecules including 
MHC class II, adhesion molecules and activation markers, by the three T cell lines 
was indistinguishable (Figure 3.1.2B). 
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Figure 3.1.2. Profiling of in vitro cultured auto-reactive T cells. (A) Dot plots of IFN/IL-17 
intracellular staining with or without PMA/ionomycin stimulation. The inserted numbers indicate the 
proportion of cells in each quadrant. Representative results are shown from four independent 
experiments. (B) Histograms depict expression of cell surface markers on in vitro activated GFP-
labeled T cells. TLE-MBP (green lines), TLE-MOG (grey lines) and TDA-MOG (red lines) cells were stained 
with specific antibodies as indicated and analyzed by flow cytometry. Representative results from two 
independent experiments are shown. 
Both, EAElo as well as EAEhi, T cells showed similar infiltration kinetics into the 
leptomeninges (Figure 3.1.3A). All T cell lines appeared on day two post transfer 
(p.t.), and then continued to massively infiltrate the meningeal area on day three and 
four in comparable numbers, regardless of their encephalitogenicity. As previously 
described (Bartholomäus et al., 2009), meningeal infiltration is followed by an 
infiltration of the parenchyma. Large numbers of highly encephalitogenic T cells 
penetrate into the CNS parenchyma on day three, increasing further on day four 
(Figure 3.1.3B). In striking contrast, EAElo TLE-MOG cells also appeared in the CNS 
parenchyma but in much lower numbers, reaching only 10% of EAEhi T cell numbers 
on both day three and four (Figure 3.1.3B). Histology confirmed that TLE-MOG cells 
remained in the leptomeninges and the Robin Virchow space at a time when TLE-MBP 
cells and TDA-MOG cells became evenly distributed within the CNS parenchyma 
(Figure 3.1.3C). 
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Figure 3.1.3. Infiltration of self-reactive effector T cells into the CNS. (A and B) T cell infiltration 
within CNS leptomeninges (A) and parenchyma (B) was quantified by flow cytometry at the indicated 
time points. Means +/- S.D. of two animals, triplicate measurements per animal, are shown. Each 
graph includes six animals per group. Representative results from at least three independent 
experiments are shown. N.D.: not detected. (C) Spinal cord cryosections were prepared at indicated 
time points after transfer of auto-reactive GFP-labeled T cells (green). Sections were stained with anti-
laminin α1 antibody (red). Images were acquired by confocal microscopy. M: CNS meninges, RV: 
Robin Virchow space. Scale bar: 50 µm. 
3.2 Intraluminal crawling is unaffected by pathogenic potential 
Upon arrival in the CNS, EAEhi TLE-MBP cells have been shown to dock on the luminal 
surface of the leptomeningeal vessels and then crawl there, preferably against the 
blood flow, potentially looking for suitable extravasation sites (Bartholomäus et al., 
2009). Two-photon imaging documented that while they are within the vascular 
lumen, initially the weakly encephalitogenic TLE-MOG cells behave in a similar way to 
their pathogenic counterparts, TLE-MBP and TDA-MOG cells (Figure 3.2.1A). About 40% 
of the observed T cells migrated against blood flow, whereas 20% moved along the 
blood stream, regardless of antigen specificity (Figure 3.2.1B). Furthermore, all T cell 
types crawled for a similar duration of time (Figure 3.2.1C) and with similar velocity 
(Figure 3.2.1D), again regardless of their antigen specificity and pathogenic 
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potential. Overall, the intraluminal locomotion of EAEhi and EAE
lo cells was 
indistinguishable. 
 
Figure 3.2.1. Intraluminal motility in the leptomeningeal vessels. Intraluminal T cell motility was 
analyzed from intravital recordings. (A) Time projections of 30 min are shown for TLE-MOG, TDA-MOG, and 
TLE-MBP cells (green) on day two p.t., when all cells are scanning the intraluminal surface of the blood 
vessels (red). Collagen fibers (blue) were detected by second harmonic generation. Scale bar: 50 μm. 
(B) Intraluminal T cell movements were categorized relative to the direction of blood flow as follows: 
Downstream: moving with the blood flow, Upstream: moving against the blood flow, and Across: 
moving at an angle of >45° of the vessel axis, or arrested, and their relative representation was 
calculated. Results were obtained from at least four different videos per cell line. Means +/- S.D. are 
shown. (C) Durations of intraluminal crawling. Fractions of T cell tracks are plotted as a function of 
their crawling duration. (D) Intraluminal velocity of GFP-expressing T cells. (C and D) Results are sum 
of at least three different experiments per cell line. ns: not significant (One-way ANOVA, Kruskal 
Wallis test - Dunn’s multiple comparison test). 
3.3 Perivascular detachment is impaired in EAElo T cells 
After extravasation, effector T cells continued to crawl on the abluminal surface of 
the vessels and finally detached to spread through the leptomeningeal space 
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(Bartholomäus et al., 2009). To compare the infiltration kinetics of EAEhi and EAElo 
T cells in more detail, 24 h long panoramic time-lapse imaging (one panoramic 
image per hour), was performed, starting on day two after T cell transfer, when the 
T cells just start to appear in leptomeninges, until the time when they are fully 
infiltrated. 
 
Figure 3.3.1. Meningeal infiltration of EAE
hi
 and EAE
lo 
T cells. Representative panoramic views of 
the meningeal infiltration by TLE-MOG (upper panels) or TDA-MOG cells (lower panels). Blood vessels are 
indicated in red. Inserted numbers represent the number of cells/mm
2
 and time after start of imaging. 
Scale bar: 100 μm. 
Confirming flow cytometric results, all T cell lines penetrated into the leptomeninges 
with similar kinetics, regardless of their encephalitogenic potential (Figure 3.3.1 and 
Figure 3.3.2A). However, the cell types’ subsequent behavior was remarkably 
different. While EAEhi cells (TLE-MBP and TDA-MOG) detachted from the perivascular 
surfaces and distributed evenly in the sub-leptomeningeal area, EAElo cells (TLE-MOG) 
failed to do so and tended to, after extravasation, accumulate in close proximity to 
the blood vessels (Figure 3.3.1 and Figure 3.3.2, B and C). 
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Figure 3.3.2. Infiltration and vessel detachment kinetics of EAE
hi
 and EAE
lo 
T cells into CNS 
meninges. (A) The numbers of T cells that have infiltrated the CNS meninges were counted from 
long-term intravital recordings. The cell numbers at indicated time points were normalized by area. 
Results were obtained from at least three animals per cell line, and combined from two independent 
experiments for TLE-MOG-GFP and TDA-MOG-GFP cell lines, and one experiment for the TLE-MBP-GFP cell line. 
(B) Kinetics of T cell detachment from leptomeningeal vessels: Detached cells were defined as 
>10 μm distance from the closest vessels. At least three animals per cell line were used. 
Representative data from two independent experiments are shown. In A and B, trend lines were 
calculated by GraphPad Prism software. R
2
 describes how well the trend line fits the data. k and 
1/slope indicate the exponential or linear trend line slope, respectively. (C) The proportions of 
detached cells from leptomeningeal vessels at day three p.t. At least four animals were used for each 
cell line. **p<0.01 (One-way ANOVA, Tukey’s multiple comparison test). 
3.4 After extravasation, EAEhi T cells have lower motility 
compared to EAElo T cells 
Next, the motility of different auto-reactive T cells upon extravasation was compared 
by analyzing their basic motility parameters. EAElo T cells (TLE-MOG) moved with 
higher velocity compared to EAEhi T cells (TDA-MOG and TLE-MBP), while the motility of 
different EAEhi cell lines was indistinguishable (Figure 3.4.1A). EAEhi T cells had a 
higher percentage of stationary cells (Figure 3.4.1C) (see material and methods), 
and were more confined comparing to EAElo (TLE-MOG) cells, indicated by their lower 
meandering index and lower mean square displacement (Figure 3.4.1, B and D). 
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Figure 3.4.1 Motility of EAE
hi
 and EAE
lo
 T cells after extravasation from leptomeningeal 
vessels. Velocity (A), mean square displacement (B), frequency of stationary cells (C) and 
meandering index (D) of TLE-MOG, TDA-MOG and TLE-MBP cells were calculated from intravital recordings. A 
and D are sum, B is representative and C display means with S.D. of at least three independent 
experiments per cell line. A and D, ***p<0.001 (One-way ANOVA, Kruskal Wallis test - Dunn’s 
multiple comparison test). C, **p<0.01 (One-way ANOVA, Tukey’s multiple comparison Test). 
3.5 EAEhi T cells stay longer in contact with perivascular APCs 
compared to EAElo T cells. 
After crossing the vascular wall, the myelin-specific T cells have been shown to 
establish contacts with local APCs (Bartholomäus et al., 2009). To test the 
hypothesis that difference in motility of EAEhi and EAElo T cells might be due to their 
different interactions with local APCs, T cell/APC contacts were analyzed in more 
detail. Meningeal phagocytes were labeled by intrathecal injection of Texas-Red 
conjugated dextran. These phagocytes exhibit mostly macrophage and not DC 
markers, and a substantial proportion expresses MHC class II molecules on their 
surface, qualifying them as APCs (Bartholomäus et al., 2009). The EAElo TLE-MOG 
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cells largely ignored the local APCs, moving continuously along straight trajectories 
(white line in upper panel of Figure 3.5.1). In contrast, the EAEhi TDA-MOG and TLE-MBP 
cells halted upon contact with APCs, drawing trajectories that twisted around an 
anchoring point (white line in the middle and lower panel of Figure 3.5.1, 
respectively). 
 
Figure 3.5.1. Contacts between infiltrated T cells (green) and perivascular/meningeal APC 
(red). Still images of representative T cell/APC contacts in the leptomeninges: TLE-MOG-GFP, TDA-MOG-GFP 
and TLE-MBP-GFP cells are shown in green, together with local APCs (red). Trajectories of the T cell 
movement are overlaid with the images. White lines represent phases when the T cell contacts an 
APC, while blue lines indicate when T cell is freely moving. EAE
lo
 (TLE-MOG-GFP cells, upper panels) or 
EAE
hi 
(TDA-MOG-GFP and TLE-MBP-GFP cells, middle and lower panels, respectively) are shown. Time scales 
are indicated. Scale bar: 10 μm. 
Detailed analysis showed that T cell/APC contacts made by EAEhi T cells were 
significantly longer lasting (average duration 7 min for TDA-MOG, and 6 min for TLE-
MBP), compared to those of EAE
lo T cells (3 min average duration) (Figure 3.5.2A). 
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The contacts of EAEhi T cells were also less frequent, but lasted longer than those of 
EAElo T cells, which instead made repeated short contacts (Figure 3.5.2B). 
 
Figure 3.5.2. Quantification of T cell/APC contacts. (A) Contact duration of TLE-MOG-GFP, TDA-MOG-GFP 
and TLE-MBP-GFP cells was calculated from intravital recordings. (B) Graph of T cell-based contacts, 
where each dot represents a single T cell plotted for the number of contacts per hour (x-axis) and 
average duration of contacts (y-axis). A and B, results are sum of at least three independent 
experiments per cell line. ***p<0.001 (One-way ANOVA, Kruskal Wallis test - Dunn’s multiple 
comparison test). 
Since contacts with local APCs lead to T cell activation (Bartholomäus et al., 2009; 
Kawakami et al., 2005), the expression of surface activation marker CD134 (OX40 
antigen), as well as spontaneous production of IFNγ and IL-17 by all T cell lines, was 
monitored using flow cytometry. As expected, TLE-MBP and TDA-MOG cells were strongly 
activated in the CNS leptomeninges compared to those in the spleen, and were 
further activated within the CNS parenchyma. In contrast, activation of TLE-MOG cells 
remained marginal (Figure 3.5.3), similar to OVA-specific control T cells (Flügel et 
al., 2001). 
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Figure 3.5.3. Activation status of auto-reactive T cells within the CNS. (A) Expression of 
activation markers by the CNS infiltrated T cells was analyzed by flow cytometry. CNS meninges and 
parenchyma were isolated at the peak of T cell infiltration. T cells were stained for the activation 
marker (OX40). Results of T cells derived from spleen (filled histograms) are overlaid with those from 
CNS meninges (green lines), and CNS parenchyma (red lines). Representative data from at least 
three independent experiments per cell line are shown. (B) Spontaneous production of inflammatory 
cytokines was evaluated by intracellular IFNγ/IL-17 staining and subsequent flow cytometry. 
Encephalitogenic T cells were prepared from spleen, CNS meninges, and parenchyma at the peak of 
infiltration. To analyze spontaneous production of inflammatory cytokines, T cells were not stimulated 
with PMA/ionomycin. Inserted numbers indicate the proportion of cells in each quadrant. 
Representative results from three independent experiments are shown. 
3.6 Exogenous myelin antigen 
One of the reasons for weak pathogenic activity of TLE-MOG cells could be their inferior 
antigen avidity. To test this, proliferative response of auto-reactive T cells to 
increasing concentrations of antigens, presented by professional dendritic cells 
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in vitro, was monitored. EAElo T cells were slightly less sensitive to limiting antigen 
doses than EAEhi T cell lines (Figure 3.6.1). However, at saturating concentrations of 
antigen, TLE-MOG cells proliferated with similar rates to TDA-MOG and
 TLE-MBP cells. 
 
Figure 3.6.1. Sensitivity of T cells against specific antigen. Antigen-specific T cells were 
stimulated by serial dilution of antigens in vitro. Proliferation was quantified by 
3
H-labeled thymidine 
up-take. Means of triplicate measurements were calculated. Results are presented as a proliferation 
index (relative 
3
H uptake, with 10 µg/ml antigen concentration normalized as 1.0). Trend lines were 
inserted by GraphPad software. Cumulative results, from at least four independent experiments, are 
shown. 
Another limiting factor for EAElo T cells could also be availability of local myelin auto-
antigens in the leptomeninges. As shown before, leptomeningeal APCs are not 
saturated with locally produced MBP antigen and addition of exogenous antigen can 
further activate TLE-MBP cells in vivo (Odoardi et al., 2007a). Thus, marginal antigen 
availability could especially affect immune responses against MOG, a minor myelin 
protein component (less than 0.1%) (Johns and Bernard, 1999). If this is the case, 
introduction of exogenous MOG into leptomeninges should provide sufficient 
activation stimulus for even low sensitive TLE-MOG cells. 
To test this, meningeal APCs from CNS leptomeninges of naive rats were prepared, 
loaded with antigen in vitro (MOG or control OVA), and then transferred intrathecally 
into animals, two days after i.v. transfer of TLE-MOG-GFP cells, the time point when they 
start to appear in leptomeningeal area. Intravital panoramic views and quantification 
by flow cytometry confirmed that transferred MOG-pulsed APC intensified 
recruitment of TLE-MOG-GFP cells by three-fold compared to the effect of control OVA-
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pulsed APCs, and enhanced infiltration into CNS parenchyma to an even greater 
extent (Figure 3.6.2). 
 
Figure 3.6.2. Intensified recruitment of TLE-MOG-GFP cells within the CNS meninges after MOG-
pulsed APC intrathecal application. (A) Overview of CNS infiltrated TLE-MOG-GFP cells after intrathecal 
application of MOG- or OVA-pulsed meningeal APCs. Intravital imaging was performed 12 h after 
APC intrathecal injection. TLE-MOG-GFP cells (green) were visualized together with Texas Red 
conjugated dextran infused blood vessels (red). Scale bar: 100 μm. (B) Quantification of infiltrated TLE-
MOG-GFP cells by flow cytometry 12 h after intrathecal MOG- (red bars) or OVA-pulsed (grey bars) APC 
injection. Means and S.D. of triplicates measurements from two animals are shown. 
Motility of TLE-MOG cells after application of MOG-pulsed APCs was reduced, as 
shown by their lowered velocity (Figure 3.6.3A), and lowered mean square 
displacement (Figure 3.6.3B). They also became more confined (Figure 3.6.3C), and 
percentage of stationary cells increased (Figure 3.6.3D) to values characteristic for 
EAEhi T cells (Figure 3.4.1C). 
TLE-MOG cells interacted with local APCs very much like highly encephalitogenic 
T cells did. They made less frequent but longer lasting contacts with APCs (Figure 
3.6.3E), with average contact duration extending from 3 to 6 min (Figure 3.6.3F). 
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Figure 3.6.3. Motility of TLE-MOG-GFP cells within the CNS meninges after MOG or OVA-pulsed 
APCs intrathecal application. Velocity (A), mean square displacement (MSD) (B), meandering index 
(C), and percentage of stationary cells (D), were calculated from intravital recordings. (E) Graph of 
T cell-based contact where each dot represents a single T cell plotted for the number of contacts per 
hour (x-axis) and average duration of contacts (y-axis). (F) TLE-MOG-GFP/APC contact duration. Imaging 
was done 12 h after intrathecal injection of MOG- or OVA-pulsed APCs. A, C, E, F are sum, B is 
representative, and D display means with S.D, of two and three independent experiments after OVA 
and MOG APC-pulsing, respectively. A, C and F, ***P<0.0001 (nonparametric t test). D, **p<0.01 
(unpaired t test). 
Finally, TLE-MOG cells were activated in the leptomeninges, after application of 
exogenous antigen (Figure 3.6.4, A and B), and they triggered clinical EAE, as 
reflected by weight loss and neurological signs (Figure 3.6.4C). Taken together, the 
increased availability of MOG by exogenous application changed the behavior of the 
TLE-MOG cells from an EAE
lo to an EAEhi pattern. 
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Figure 3.6.4. Activation status and encephalitogenic potential of TLE-MOG cells after MOG-pulsed 
APC intrathecal application. (A) CD134 expression (OX40) as T cell activation marker was 
examined. Staining on T cells derived from OVA-pulsed APC-treated animals (filled histogram) were 
overlaid with results obtained from MOG-pulsed APC-treated (red lines) animals in the spleen and 
CNS meninges. (B) Production of IFNγ and IL-17 in the T cells after OVA- or MOG-pulsed APC 
treatment. (C) Clinical outcome after antigen-pulsed meningeal APC intrathecal injection was 
evaluated. Relative body weight (lines, left y-axis) and clinical score (bars, right y-axis) after OVA- 
(grey) or MOG- (red) pulsed APC treatments are shown. The arrow indicates the time point of 
intrathecal antigen-pulsed APCs injection; two animals per group. Representative data of four 
independent experiments are shown (means +/- S.D.). 
The disadvantage of the approach using antigen-pulsed APCs is that quantification 
of T cell/APC contacts is performed with all APCs, as pulsed and non-pulsed APCs 
are indistinguishable, due to technical limitation. To identify leptomeningeal 
phagocytes actively involved in processing local antigen, self-quenched MOG 
(MOGDQ) was injected intrathecally. In its native conformation, MOGDQ quenches 
itself, and is unable to emit fluorescent signal. However, once taken up by APCs and 
cleaved by intracellular proteases, MOGDQ becomes brightly fluorescent (Lewis and 
Cobb, 2010). MOGDQ or OVADQ was injected intrathecally on day 2.5 after TLE-MOG-
GFP cell transfer, and motility and contact duration between TLE-MOG-GFP cells and 
stained APCs were analyzed. TLE-MOG-GFP cells showed confined movement during 
the contact with APCs that had processed MOGDQ, resulting in zig-zag traces within 
small area (Figure 3.6.5A). Their velocity was reduced and they became more 
confined, as shown by lowered MSD (Figure 3.6.5, B and C). Additionally, the 
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duration of contacts with local APCs was extended to a period characteristic for 
EAEhi T cells (Figure 3.6.5D). 
 
Figure 3.6.5. TLE-MOG-GFP cell motility in the CNS meninges after intrathecal MOGDQ or OVADQ 
application. (A) Images are taken from representative video for TLE-MOG-GFP/APC contacts after 
application of MOGDQ. Trajectory lines were overlaid. Inserted numbers indicate relative time after the 
start of image acquisition. Scale bar: 10 µm. (B,C, and D) Instantaneous velocity (B), Mean square 
displacement (MSD) (C), and T/APC contact duration (D) were analyzed. Results were summed (B 
and D) or representative (C) from two and four different experiments after OVA
DQ
 or MOG
DQ
 
application respectively. ***P<0.0001 (nonparametric t test) 
In vivo observations were supported by in vitro experiments. TLE-MOG cells were 
confronted by APC freshly prepared from CNS meninges with or without exogenous 
antigen. Expression of intracellular IFNγ was used as a sensitive marker of rat T cell 
activation (Kawakami et al., 2004). Although naive meningeal APCs alone failed to 
stimulate IFNγ production in TLE-MOG cells, addition of exogenous MOG induced the 
cytokine in a substantial proportion of cells (Figure 3.6.6). Thus, TLE-MOG cells 
essentially behaved like OVA-specific T cells. In contrast, encephalitogenic TLE-MBP 
cells and TDA-MOG cells produced IFNγ upon contact with meningeal APCs even in the 
absence of exogenous antigen, i.e. in response to endogenous MBP and MOG, 
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respectively. All T cell lines were stimulated to produce high levels of IFNγ when 
appropriate antigen was presented by thymus derived professional APCs (DCs) 
(Figure 3.6.6) 
 
Figure 3.6.6. In vitro stimulation of encephalitogenic T cell lines by CNS local APCs. 
Encephalitogenic T cell lines were cultured with CNS-APCs in the absence of exogenous antigens. 
CNS-APCs were prepared from either syngeneic or F1 rats. Thymocytes together with exogenous 
antigens served as positive controls. Additionally TLE-MOG-GFP cells were stimulated with MOG-pulsed 
CNS-APCs. 48 hours after co-culture, T cells were stained with anti IFNγ antibody and analyzed by 
flow cytometry. Representative results from three independent experiments are shown. 
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3.7 Transfer into F1 recipients 
According to a previous report, Lewis rat myelin contains lower levels of MOG than 
myelin from rats with high encephalitogenic responsiveness (Pagany et al., 2003), 
and this difference may be a reason for low encephalitogenic potential of TLE-MOG 
cells in the Lewis rat. To explore this possibility, TLE-MOG or TDA-MOG cells were 
separately transferred into F1 (LE x DA) rats, and their behavior was followed in vivo 
by intravital imaging. The behavior of both effector cells in F1 recipients replicated 
their activities in parental hosts. In F1 rats, EAEhi TDA-MOG cells showed a low and 
confined motility (Figure 3.7.1, A and B), and formed extended contacts with local 
APCs (Figure 3.7.1C). Conversely, EAElo TLE-MOG cells transferred into F1 rats had 
higher velocity and MSD (Figure 3.7.1, A and B), and showed shorter APC contacts 
(Figure 3.7.1C). 
 
Figure 3.7.1. TLE-MOG-GFP and TDA-MOG-GFP cells in the CNS meninges of F1 (LExDA) rats. Velocity 
(A), mean square displacement (MSD) (B), and duration of T cell/APC contacts (C), was calculated 
from intravital recordings. Results are sum from three different experiments per cell line. ***P<0.0001 
(nonparametric t test) 
Additionally, TDA-MOG cells were activated within the CNS of F1 recipients, like they 
were in DA recipients, while TLE-MOG cells in F1 also like in Lewis rats remained 
resting (Figure 3.7.2A). TDA-MOG, in contrast to TLE-MOG cells, induced clinical EAE in 
the F1 hosts (Figure 3.7.2B). The milder neurological disorder mediated by TDA-MOG in 
F1 rats, compared to DA rats, can be attributed to a gene dosage effect of DA-
derived MHC II RT1 (Ben-Nun et al., 1981). In vitro experiments also confirmed that 
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CNS-derived APCs from F1 rats, presenting endogenous myelin antigens, can 
activate EAEhi TLE-MBP and TDA-MOG cells, but not EAE
lo TLE-MOG cells, as evaluated by 
intracellular IFNγ production (Figure 3.6.6). The similar activity of TLE-MOG cells and 
TDA-MOG cells in parental as in F1 hosts argues against different MOG-expression 
levels as an explanation for different T cell encephalitogenicity between LE and DA 
hosts. 
 
Figure 3.7.2. Activation status and encephalitogenic potential of MOG-specific T cells in F1 
recipients. (A) Expression of the surface T cell activation marker (OX40) was analyzed by flow 
cytometry. Expression on TDA-MOG-GFP cells (red overlaid lines) was compared to TLE-MOG-GFP cells (filled 
histograms) in both CNS meninges and parenchyma. Representative results from two independent 
experiments are shown. (B) EAE clinical course evaluated by body weight change (lines, left y-axis) 
and clinical score (bars, right y-axis) after transfer of TDA-MOG-GFP cells (red) or TLE-MOG-GFP cells (grey) 
are shown. Results are means +/- S.D. of three animals. Representative results from four 
independent experiments are shown. 
3.8 The effect of a pro-inflammatory milieu 
The interaction of effector T cells with BBB and CNS parenchyma can be also 
influenced by the local microenvironment. To test the effect of a pro-inflammatory 
milieu on the behavior of EAElo T cells, LPS was intrathecally injected, opening the 
BBB and activating local phagocytes. However, this did not change the motility of 
TLE-MOG cells (Figure 3.8.1A) or duration of their contacts with meningeal APCs 
(Figure 3.8.1B). Accordingly, TLE-MOG cells were not activated in the CNS (Figure 
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3.8.1C). These results suggest that the duration of interactions between T cells and 
APCs is highly antigen-dependent and does not depend on inflammatory conditions. 
 
Figure 3.8.1. Motility and activation of TLE-MOG cells under inflammatory conditions induced by 
LPS. Animals were intrathaceally injected with LPS two days after i.v transfer of TLE-MOG-GFP cells. 
Imaging was performed 12 h later. Velocity (A), and T cell/APC contact duration (B) were calculated 
from intravital recordings. Results are sum of at least two different experiments per condition. (C) 
Expression of surface T cell activation marker (OX40) was analyzed by flow cytometry. TLE-MOG-GFP 
cells were isolated 16 h after LPS treatment from spleen, CNS meninges and parenchyma. 
Expression without treatment (field histograms), was overlaid with expression after LPS treatment 
(green lines). Results are representative from two independent experiments. ns: not significant, 
*p<0.01 (nonparametric t test). 
3.9 ∆NFAT-GFP as fluorescent marker of T cell activation in vivo 
Previous experiments suggest that auto-reactive T cells receive an activation 
stimulus from meningeal/perivascular APCs, and that longer lasting contacts provide 
a sufficient signal for the T cell activation. However, with this experimental approach 
distinguishing productive from non-productive interactions was not possible. To 
directly link T cell/APC contacts with T cell activation, a truncated NFAT fused to 
GFP (∆NFAT-GFP) was introduced as fluorescent “functional” tag, and used to 
visualize activation events in auto-reactive T cells interacting with structures of the 
BBB. 
The ∆NFAT-GFP construct contained the regulatory domain of NFAT1, which is 
necessary for phosphorylation, cytoplasmic sequestration, and calcium-induced and 
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calcineurin-mediated dephosphorylation. Dephosphorylation induces a 
conformational change, which exposes a nuclear localization signal leading to the 
translocation of NFAT from the cytoplasm to the nucleus (Hogan et al., 2003; 
Okamura et al., 2000). The NFAT construct was truncated to delete the DNA-binding 
domain of native NFAT (Aramburu et al., 1998) (Figure 3.9.1A), so as not to interfere 
with the gene regulation by endogenous NFAT. To visualize the subcellular 
localization of truncated NFAT, GFP was fused to C-terminal. Upon T cell activation, 
∆NFAT-GFP is translocated from the cytoplasm to the nucleus, similar to native 
NFAT1 (Shaw et al., 1995) (Figure 3.9.1B). 
 
Figure 3.9.1. ∆NFAT-GFP as activation marker of T cells. (A) Schematic of naive and truncated 
version of NFAT. Numbers indicate amino acid. (B) Confocal images of a resting in vitro TMBP-NFAT-GFP 
cell stained with the red membrane dye PKH26 and DAPI, before and after application of ionomycin. 
Scale bar: 2 μm. 
Two-photon microscopy can only resolve processes of a certain temporal range (few 
seconds to few hours). Therefore, the in vitro kinetic of the ∆NFAT-GFP 
translocation, from cytosol to the nucleus (c-n) upon stimulation, as well as back to 
the nucleus (n-c) after removing the activation stimulus, was investigated. 
Translocation of ∆NFAT-GFP from cytosol to nucleus happened within only few 
minutes upon ionomycin stimulation; however, the reverse transport took much 
longer (around 1 h) (Figure 3.9.2). 
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Figure 3.9.2. Dynamics of ∆NFAT-GFP translocation. (A) Fluorescent video-microscopy of ∆NFAT-
GFP translocation from cytosol to nucleus (upper panel) upon ionomycin stimulation, and back to the 
cytosol (lower panels) after washing out the ionomycin, in representative resting in vitro TMBP-NFAT-GFP 
cells. Bright field images (grey) were overlaid with pseudo color images depicting GFP intensity 
distribution (from blue - low intensity, to red - high intensity). Inserted numbers indicate the relative 
time after addition or removal of ionomycin, respectively. Scale bar: 5 μm. (D) ∆NFAT-GFP 
translocation times from cytosol to nucleus (c-n) after addition of ionomycin, and back to the cytosol 
(n-c) after washing ionomycin out. Each dot represent single cell. Result is sum of at least three 
independent experiments per condition. 
∆NFAT-GFP-expressing T cells behaved like their GFP-expressing counterparts; 
especially, their encephalitogenic potential remained unimpaired (Figure 3.9.3). All 
these facts indicated that ∆NFAT-GFP can serve as a reliable genetic indicator of 
T cell activation for two-photon imaging without disturbing cellular function. 
As no difference between the two investigated EAEhi T cell lines (TDA-MOG and TLE-
MBP) was seen previously, TLE-MBP-NFAT-GFP cells were chosen as EAE
hi and TLE-MOG-
NFAT-GFP cells as EAE
lo, for the study of differential T cell activation in vivo, using 
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∆NFAT-GFP as a marker. For clarity, they will from now on be referred to as TMBP 
and TMOG, as they have the same recipient rat strain. 
 
Figure 3.9.3. Comparison of the EAE-course induced by ∆NFAT-GFP-expressing T cells and 
their GFP-expressing counterparts. EAE clinical course induced by transfer of TMOG/MBP-GFP cells as 
well as TMOG/MBP-NFAT-GFP cells. Means+/-S.D. from at least three animals per group are shown. 
Representative data from three independent experiments per cell line are shown. 
3.10 Activation status of intraluminal T cells 
The marker was first used to investigate activation status of intraluminal auto-
reactive T cells, during their initial encounter with the BBB. T cells attach to the 
intraluminal surface, first roll and then crawl on the endothelial cells. Both modes of 
motion differ in the molecules used for endothelial contacts. Rolling involves 
transient interactions between selectins and glycoproteins (Engelhardt, 2006), and 
crawling depends on the binding of integrins (Bartholomäus et al., 2009). These 
interactions appear to involve some stimulation effect of the T cells (Engelhardt, 
2006); however, it is not clear which of the endothelial contacts trigger activation, 
and to what level of stimulation the T cells are driven within the vascular lumen. Two-
photon imaging showed, that regardless of their pathogenic potential (EAEhi vs. 
EAElo T cells), both the crawling and the rolling T cells restricted ∆NFAT-GFP to their 
cytosol (Figure 3.10.1). This result indicates that, if there is any stimulation of 
intraluminal T cells, it is not sufficient to translocate NFAT into the nucleus, and 
further initiate gene activation. 
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Figure 3.10.1. Activation status of auto-reactive T cells within leptomeningeal blood vessels. 
Images taken from representative videos, showing crawling (A) and rolling (B) of TMBP-NFAT-GFP cells. 
White arrowheads: ∆NFAT-GFP-spared nuclei. Scale bar: 10 μm. 
3.11 ∆NFAT-GFP translocation in perivascular T cells 
Next, ∆NFAT-GFP localization in EAEhi (TMBP-NFAT-GFP) and EAE
lo (TMOG-NFAT-GFP) cells 
was compared upon their extravasation. For improving the visualization of the 
marker’s subcellular location, the cells were additionally stained with SNARF-1 
(Bousso et al., 2002), which labels both the cytosol and nucleus. To avoid the 
dilution of SNARF-1 staining by the extensive cell division in first three days after 
T cell transfer, the CD4+ T cells isolated from spleen, 3 days after transfer of NFAT-
GFP T cells, were labeled and then transferred into wild type recipients (Figure 
3.11.1). At this time, the T cells have already assumed their migratory phenotype, 
and the retransferred T cells infiltrate the CNS quicker than in vitro activated T cells 
(Flügel et al., 2001). 
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Figure 3.11.1. Schematic overview of “migratory” TMBP/MOG-NFAT-GFP cells retransferred from the 
donor spleen into wild type recipient. Spleens were collected from donor animals three days after 
the i.v. transfer of the TMBP/MOG-NFAT-GFP cells. CD4
+
 T cells were purified from the spleen, using a CD4
+
 
T cell isolation kit, and were labeled with SNARF-1. This mixed population of SNARF-labeled antigen-
nonspecific (no ΔNFAT-GFP expression) single positive (red), and antigen-specific ΔNFAT-GFP- and 
SNARF-labeled double-positive (red/green) cells, was injected into WT recipients. Imaging was 
performed 12 h after re-transfer. 
SNARF-1 counterstaining allowed the determination of the ∆NFAT-GFP location in 
up to 90% of all cells and facilitated the distinction of three ∆NFAT-GFP patterns: 
cytoplasmic (c), located in the cytosol and not the nucleus in resting T cells; nuclear 
(n), in the nucleus and not the cytosol in activated cells; and both in the cytoplasm 
and nucleus (nc) of transitional cells (Figure 3.11.2A). 
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Figure 3.11.2. Perivascular T cell activation indicated by the cellular localization of the ∆NFAT-
GFP marker. (A) Three patterns of ∆NFAT-GFP (green)/SNARF-1 (red) in double-labeled T cells. 
Cytosolic (c), nuclear (n), and nuclear/cytosolic (nc). Scale bar: 5 μm. (B) Snapshots of TMOG/MBP-NFAT-
GFP cells in the CNS. Scale bar: 10 μm. (C) ∆NFAT-GFP patterns (A) in the TMOG/MBP-NFAT-GFP cells 
were categorized, and their relative occurrence calculated. n.a.: not analyzable. (D) T cell trajectories 
from representative movies were superimposed; each line starts at the coordinate origin. Lines were 
colored to indicate the ∆NFAT-GFP location. Results for B, D are representative and for C are mean 
with indicated S.D, from at least three different experiments per cell line. 
Unlike intraluminal T cells, more than 30% of the extravasated EAEhi TMBP-NFAT-GFP 
cells showed a nuclear localization of ∆NFAT-GFP (n), and another 20% had the 
marker located both in the cytosol and nucleus (nc). However, the EAElo TMOG-NFAT-
GFP cells restricted ∆NFAT-GFP to the cytoplasm (Figure 3.11.2, B and C). 
Subcellular localization of the marker correlated to the locomotion behavior of 
T cells. Regardless of their antigen-specificity and encephalitogenic potential (EAEhi 
or EAElo), T cells with cytosolic ∆NFAT-GFP were highly motile, with nearly straight 
trajectories (black lines in Figure 3.11.2D). In contrast, T cells with nuclear ∆NFAT-
GFP showed a confined zig-zag movement (red lines in Figure 3.11.2D). 
RESULTS 
 
60 
 
T cell velocity was also tightly related with the ∆NFAT-GFP localization. T cells 
having ∆NFAT-GFP in the cytosol (c) moved at high velocity (average 10 μm/min), 
again regardless of their encephalitogenic potential, whereas T cells with ∆NFAT-
GFP in the nucleus (n) traveled at a slow velocity (mean 4.5 μm/min). Finally, T cells 
with both nuclear and cytosolic ∆NFAT-GFP (nc) moved with an intermediate speed 
(mean 6.5 μm/min) (Figure 3.11.3A). As shown by one representative cell (Figure 
3.11.3B), the ∆NFAT-GFP translocation correlated with the changes in T cell 
velocity. 
 
Figure 3.11.3. T cell velocity correlates with the subcellular ∆NFAT-GFP localization. (A) 
Velocity of T cells with different ∆NFAT-GFP localizations was calculated from intravital recordings. 
Results are the sum of at least three different experiments per cell line. (B) Velocity (averaged over 
three time points) of a representative TMBP-NFAT-GFP cell changing the ∆NFAT-GFP localization. Light 
and dark red colors indicate ∆NFAT-GFP in the nucleus/cytosol (nc) and the nucleus (n), respectively. 
Top-row images depict the ∆NFAT-GFP localization in a SNARF-1-labeled TMBP-NFAT-GFP cell 
(red/green) at the indicated time points (in min). ***p<0.001 (One-way ANOVA, Kruskal-Wallis test - 
Dunn’s multiple comparison test). 
3.12 Contacts with local APCs are crucial for T cell activation 
The nuclear translocation of ∆NFAT-GFP in the T cells correlated with their contacts 
to the local APCs (Figure 3.12.1). Note that in Figure 3.12.1 the same APC that had 
activated T cell #1 interacted with T cell #2, triggering ∆NFAT-GFP translocation. In 
fact, sequential T cell activation by one APC was not unusual. This indicates that 
APCs differ in their capacity to activate T cells, and some particular APCs are more 
potent in activating T cells than the others. This is in harmony with our previous 
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results, showing that only a fraction of the dextran-labeled cells expressed MHC 
class II (Bartholomäus et al., 2009). 
 
Figure 3.12.1. ∆NFAT-GFP translocation correlates with T cell/APC contacts. Images from a 
representative movie, showing two SNARF-labeled TMBP-NFAT-GFP cells (red/green) getting successively 
activated (nuclear translocation of ∆NFAT-GFP) following the contact with the same APC (cyan, 
speculated outline indicated by a dotted line). Closed arrowheads point to the T cell/APC interaction 
leading to ∆NFAT-GFP translocation from cytosol to nucleus (c-n), and the open arrows indicate the 
T cell of interest. Relative time after start of acquisition is indicated. Inserts show snapshots of the 
T cells (in green and red channel only) at a higher magnification. Scale bar: 10 μm. 
Prolonged APC contacts (average duration 20 min) were required to translocate 
∆NFAT-GFP from cytosol to the nucleus (c-n), whereas brief interactions (average 
duration 3 min) did not affect the ∆NFAT-GFP localization (it remained in cytosol – 
c), irrespective of the T cell antigen-specificity, and pathogenic potential (EAEhi vs. 
EAElo) (Figure 3.12.2A). Additionally, analysis showed that the cytoplasmic-nuclear 
translocation of ∆NFAT-GFP occurred shortly after the contact with an APC (mean 
lag time 4 min), whereas the average duration of this contact was still extended to 
20 min (Figure 3.12.2B). Although the longest T cell/APC contacts were the ones 
leading to translocation of ∆NFAT-GFP from cytosol to nucleus (c-n), extended 
interactions were also observed to be formed with the APCs (average duration 
10 min) by the T cells having acquired a nuclear ∆NFAT-GFP (n) elsewhere (Figure 
3.12.2A). This suggests that already activated T cells continue to visit successively 
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other local APCs and that these interactions either maintain their activation state at a 
particular level or intensify it. 
 
Figure 3.12.2. Quantification of T cell/APC contacts. (A) Duration of the T cell/APC contacts by 
cells with different ∆NFAT-GFP locations (c, nc, and n) and contacts leading to cytosol-nuclear 
∆NFAT-GFP translocation (c-n). (B) Time required for the ∆NFAT-GFP translocation, starting at the 
beginning of the T cell/APC contact, as compared to the total duration of the same contact. Each color 
represents the same contact. Results are the sum of three independent experiments per cell line. 
***p<0.001 (One-way ANOVA, Kruskal-Wallis test - Dunn’s multiple comparison test) 
Unlike the cytosol-nuclear (c-n) translocation of ∆NFAT-GFP, which happened within 
minutes after T cell/APC contact, the reverse transport of ∆NFAT-GFP from the 
nucleus to the cytoplasm (n-c) required a longer period of time. Once detached from 
the APC, ∆NFAT-GFP was gradually translocated back to the cytosol, a process 
requiring approximately 30 min (Figure 3.12.3). Thus, ∆NFAT-GFP translocation 
kinetics observed in vivo (both c-n as well as n-c) correlated with in vitro obtained 
results (Figure 3.9.2). 
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Figure 3.12.3. Translocation of ∆NFAT-GFP from the nucleus back to the cytosol (n-c). (A) 
Images taken from a representative movie show SNARF-labeled TMBP-NFAT-GFP (red/green) cell, 
translocating ∆NFAT-GFP from the nucleus back to the cytosol (n-cn-c in images) after detachment 
from a local APC (cyan). Closed arrowheads point to the T cell/APC interaction, and the open arrows 
indicate the cell of interest. Relative time after start of the acquisition is indicated. Inserts show 
magnifications of the T cells (in green and red channel only). Scale bar: 10 μm. (B) Time required for 
the ∆NFAT-GFP to be translocated from nucleus back to the cytosol (n-c). Each dot represents a 
single cell. Results are the sum of three independent experiments. 
Finally the question was addressed, if rather sequential or stable T cell/APC 
interactions induce the T cell activation. Each T cell makes two types of contact, “non 
activating” and “activating”, which can be distinguished by the ∆NFAT-GFP 
localization. “Non activating” contacts that precede the “activating” ones were 
analyzed in more detail. “Non activating” contacts are short lasting (average duration 
3 min, Figure 3.12.4) compared to “activating” ones (average duration 20 min, c-n in 
Figure 3.12.2 and Figure 3.12.4), and during this “non activating” contacts, T cells 
keep their motility high (average 9 µm/min. Figure 3.12.4). Although the possibility 
that a cell is receiving some stimulus during these APC visits cannot be excluded, 
the results indicate that single, long contacts are more important for T cell activation. 
RESULTS 
 
64 
 
 
Figure 3.12.4. Characterization of T cell-APC interactions prior to TMBP-NFAT-GFP cell activation. 
(A) Contact duration, and T cell velocity during contact, was quantified for “non activating” (before c-n) 
and “activating” (c-n) contacts. Duration of activating (c-n) contacts was taken from Figure 3.12.2, and 
plotted here for better comparison. Results are the sum of five videos from three independent 
experiments. (B) Instantaneous velocity (averaged over three time points) for two representative TMBP-
NFAT-GFP cells, making various “non-activating” (before c-n) contacts with APCs and finally making the 
“activating” one (c-n). Line color indicates ∆NFAT-GFP subcellular localization, and background color 
indicates T cell/APC interaction. ***p<0.0001 (nonparametric t test). 
3.13 Antigen availability and T cell activation in the CNS 
meninges 
As shown by the GFP-expressing T cells, EAElo TMOG cells are not reactivated in the 
leptomeningeal area (Figure 3.5.3); they are highly motile, and only briefly interacting 
with perivascular APCs (Figure 3.4.1 and Figure 3.5.2). However, once antigen was 
externally provided, either by application of MOG-pulsed APCs (Figure 3.6.3) or by 
injection of MOG protein itself (Figure 3.6.5), they became activated (Figure 3.6.4), 
their motility was reduced and the duration of the T cell/APC contacts was extended. 
This suggested that the discrepant interactions may reflect a difference in the 
availability of presented auto-antigen. To explore the effect of the auto-antigen 
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availability on the ∆NFAT-GFP expressing TMOG cells, CNS-APCs were saturated 
with exogenous MOG by local infusion into the imaging window using a 
microcapillary. 
The effect of the exogenous auto-antigen on the subcellular ∆NFAT-GFP localization 
in TMOG-NFAT-GFP cells was drastic and immediate. The injection of MOG induced the 
nuclear translocation of ∆NFAT-GFP in up to 60% of the analyzed cells (Figure 
3.13.1, A and B), which was more than in TMBP-NFAT-GFP cells without the exogenous 
antigen (Figure 3.11.2C), leaving hardly any cells in intermediate state (nc). 
 
Figure 3.13.1. TMOG-NFAT-GFP cell activation by exogenous supply of antigen. (A) Representative 
images of SNARF-labeled TMOG-NFAT-GFP cells (red/green) interacting with local APCs (cyan) before and 
after the local application of MOG-protein. Scale bar: 10 μm. (B) Proportion of ∆NFAT-GFP patterns 
(cytosolic-c, nuclear-n, cytosolic and nuclear-nc) in TMOG-NFAT-GFP cells analyzed before and after the 
local application of MOG-protein. Results show mean values with S.D. of at least three independent 
experiments per condition. na: not analyzable. 
The locomotion of TMOG-NFAT-GFP cells was influenced by exogenous MOG only in 
cells receiving an activation stimulus (translocation of ∆NFAT-GFP into nucleus - n), 
showing confined coiled tracks (red lines in Figure 3.13.2A), while cells retaining 
∆NFAT-GFP in their cytosol were highly motile before and after antigen application 
(black lines in Figure 3.13.2A). The cell velocity was also changed by MOG infusion 
accordingly (Figure 3.13.2B). Similar to EAEhi TMBP-NFAT-GFP cells, TMOG-NFAT-GFP cells 
with cytosolic ∆NFAT-GFP (c) moved at an average of 10 μm/min, before and after 
antigen application, whereas the cells with nuclear ∆NFAT-GFP (n) slowed down 
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drastically (average velocity 3 μm/min), which again supports that T cell motility 
directly correlates with ∆NFAT-GFP localization and hence T cell activation. 
 
Figure 3.13.2. TMOG-NFAT-GFP cell motility before and after MOG infusion. (A) T cell trajectories from 
representative movies before and after MOG infusion, were superimposed on the coordinate origin. 
Lines were colored to indicate the ∆NFAT-GFP location. na: not analyzable. (B) Velocity of T cells 
with different ∆NFAT-GFP locations were calculated from intravital recordings, before and after 
antigen application. Results are the sum of three different experiments per condition. ***p<0.001 
(One-way ANOVA, Kruskal-Wallis test - Dunn’s multiple comparison test) 
T cell/APC contact of resting TMOG-NFAT-GFP cells (c) remained brief, regardless of the 
antigen availability; while the ones that led to ∆NFAT-GFP nuclear translocation (c-n) 
were long lasting, as well as the contacts made by T cells which had previously 
acquired activation (n) (Figure 3.13.3A). This suggests that the T cells displaying 
nuclear ∆NFAT-GFP (n) were contacting the APCs to maintain their activation status, 
similar to the APC interactions observed with MBP-specific T cells. Since NFAT 
nuclear translocation leads to gene transcription, the T cell activation was confirmed 
by flow cytometry. As shown in Figure 3.13.3B, TMOG cells were activated only after 
the soluble MOG treatment. Taken together, the increased availability of exogenous 
MOG translocated ∆NFAT-GFP into the nucleus of EAElo TMOG-NFAT-GFP cells and 
changed their motility accordingly, following the same patterns as EAEhi TMBP-NFAT-GFP 
cells.  
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Figure 3.13.3. Contact duration of TMOG-NFAT-GFP cells before and after antigen injection, and their 
following activation. (A) Duration of the APC contacts made by TMOG-NFAT-GFP cells with different 
∆NFAT-GFP locations (c, nc, and n) and contacts leading to cytosol-nuclear ∆NFAT-GFP 
translocation (c-n), was quantified before and after MOG infusion. Results are the sum of three 
independent experiments per condition. (B) Expression of the activation marker (OX40) on CNS-
infiltrating TMOG-NFAT-GFP cells after intrathecal application of OVA or MOG antigen. Representative 
results from three independent experiments. ***p<0.001 (One-way ANOVA, Kruskal-Wallis test - 
Dunn’s multiple comparison test). 
3.14 T cell activation state in peripheral lymphoid organs and CNS 
parenchyma 
On their way to the CNS, T cells acquire a “migratory phenotype” in peripheral 
lymphoid organs such as spleen, down-regulating activation markers, and up-
regulating chemokine receptors (Flügel et al., 2001). Therefore, the subcellular 
localization of ∆NFAT-GFP in TMBP-NFAT-GFP cells was investigated in peripheral 
organs just before they invade the CNS. 
In peripheral lymphoid organs, ∆NFAT-GFP was restricted to the cytosol of EAEhi 
TMBP-NFAT-GFP cells (Figure 3.14.1, A and C). However, the marker was translocated 
into the nucleus within minutes upon i.v. application of MBP protein (Figure 3.14.1A). 
This is in line with previous reports, describing T cell activation in the spleen upon 
antigen application, detected by flow cytometry and quantitative PCR (Odoardi et al., 
2007b). TMBP-NFAT-GFP cells that infiltrated deep into the CNS parenchyma had similar 
patterns of ∆NFAT-GFP cellular localization (c, cn, and n) as those in leptomeninges 
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(Figure 3.14.1B), confirming that reactivation in leptomeninges guides immigrant 
T cells further into the CNS parenchyma. 
 
Figure 3.14.1. Subcellular localization of ∆NFAT-GFP in peripheral lymphoid organs and the 
CNS parenchyma. (A) Images of SNARF-labeled TMBP-NFAT-GFP cells (red/green) in spleen, before and 
after i.v. application of MBP protein. (B and C) Confocal images of CNS parenchyma (B), and 
parathymic LN (C), stained with the T cell marker W3/13(red), three days after transfer of TMBP-NFAT-GFP 
cells (green) Scale bar: 10 μm. (A, B, and C) Results are representative of at least three independent 
experiments. 
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3.15 Modeling of T cell/APC interactions in the leptomeningeal 
area 
This work was designed to model T cell activation in leptomeningeal area, by a 
theoretical physics approach, using the previously generated two-photon imaging 
data. 
There are two hypotheses, explaining how T cells can receive their activation signal: 
1) A T cell can scan APCs until it finds the one presenting the right 
antigen, and make long contact which induces T cell activation 
2) A T cell can scan APCs, staying with each of them for relatively short 
periods of time (even with the ones that carry the specific antigen), 
thereby accumulating an activation signal along the way, until a certain 
threshold is exceeded, which leads to T cell activation. 
Both of these hypotheses will be considered, starting from the assumption that the 
T cells would evolutionary prefer a concept that is energetically cheaper for them, 
and theoretically obtained values will be compared with the experimental results. 
3.15.1 Basic model assumptions 
In order to become activated, T cells must first scan many APCs until they find the 
one presenting their specific antigen and they receive the activation signal while 
interacting with it. It is considered here that, in order to become activated, T cells 
must first spend energy to find a right APC (Efind), and then spend energy to 
become activated (Eact). It is assumed that energy consumption is linear over 
time      ⁄ . 
The total energy that a T cell will spend in each of the two suggested hypotheses is: 
Hypothesis I: 
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Hypothesis II: 
         
      
  
       
     
  
      
Tfind   Time that a T cell needs to find the APC with the right antigen 
T1act   Average length of one contact that would lead to full activation 
T2act  Average length of many short accumulating contacts 
N   Number of short activating contacts that a T cell must make until activation 
threshold is exceeded 
In the next section, the finding and the activating component of the total energy a 
T cell must spend on its activation, will be discussed in more detail. 
3.15.2 T cell in search of an activating APC 
 
Figure 3.15.1. Schematic illustration of the basic model assumptions. A T cell of radius r and its 
closest APC of radius a. R is a distance between them and irregular line represent the path T cell will 
take until it reaches an APC assumed it follows a random walk. 
Imaging data show that, in the process of scanning, T cells are moving randomly in a 
Brownian motion. An average time ( ) that a T cell of radius r needs to spend to 
contact the closest APC of radius a (Figure 3.15.1) is given as: 
  
  
        
  (Castro, 2011) 
R is an average distance between the T cell and the closest APC, and Dt represents 
the diffusivity of T cells and can be experimentally calculated as: 
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 (Lythe, 2011) 
∆x represents the cell displacement and ∆t is the time between two imaging frames. 
Upon T cell/APC contact, the T cell needs to scan the surface of the APC, in search 
for the one that can activate it. For simplicity it is assumed, that a T cell is able to do 
this while simply passing by an APC. The time the T cell will need for this is: 
   
   
    
 (Lythe, 2011) 
        – Distance T cell must travel while passing by (scanning) an APC. 
If   is the probability that the T cell/APC contact is activating one, then the T cell 
must contact in average: 
  
 
 
 APCs, to find the activating one. 
For this a T cell needs to spend time according to the following equation: 
              
      
 
 
 
  
        
 
         
    
  
It can be assumed, that during its migration the T cell spends energy per time unit: 
      
  
                    (Castro, 2011) 
µ represent viscosity of the medium (we can consider that is water), and   is average 
T cell velocity. The total energy that a T cell spends for finding an activating APC is:  
      
      
  
        
 
 
 
  
        
 
         
    
  
  can be experimentally calculated from   
∑  
 
 
 
  
, and    from    
∑   
 
 
 
  
 
Putting this back to the equation for       gives: 
      
    ∑    
     ∑   
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Since ∆t can be considered as constant, (during two-photon imaging, the time 
between two scans is constant),       depends on the cell displacement as 
 ∑     
∑   
 
This part of the system was modeled based on two-photon imaging data. Values for 
R, r and a could be obtained from experimental data. Also, from experiments where 
∆NFAT-GFP was used as T cell activation indicator, the probability of a T cell getting 
activated upon a random APC contact could be calculated as: 
  
                         
                   
      
Knowing these parameters, it was modeled in MATLAB, how  ,  ,  , and       
depend on different mean displacements. The idea is, that one value of    is chosen 
as a mean displacement, and others around it are modeled by Gaussian distribution 
(with random possibility that any of them occurs). This was performed for a range of 
mean displacements, and dependency graphs were obtained (Fig. 3.15.2). 
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Figure 3.15.2. Mean displacement (∆x) dependency graphs modeled in MATLAB. Dependency of 
T cell velocity ( ), diffusivity (Dt), activating APC searching time ( ) and the energy a T cell spends on 
finding a right APC (     ) from mean cell displacement (∆x) were modeled in mat lab using 
previously described formulas. Red circles on graphs represent values for experimental mean 
displacement (4.23 µm). 
This indicated that Efind has an exponential dependency on the mean cell 
displacement, suggesting that, for increasing its speed, the T cell spends 
exponentially more energy, but in contrast less time for APC searching. 
Nevertheless, there is a plateau when the increase of speed stops being 
energetically expensive for the T cell, from which the T cell could theoretically 
benefit. However, the experimentally calculated value (red circles in Figure 3.15.2) is 
not on the plateau. Based on the current model, the time a T cell needs to just pass 
by an APC (ts) could be calculated to be 3 min, which fits very well with the 
experimental values of the average EAElo T cell/APC contact duration (3 min). It 
could also be estimated that a T cell would need an average of 16 contacts until it 
finds an APC being able to activate it, and for this it would need around 2 h. 
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3.15.3 Correlation between Tfind and Tact 
As discussed before, the influx of Ca2+ ions is one of the first crucial steps in the 
cascade of T cell activation. The time course of this influx is depicted in figure 3.15.3: 
 
Figure 3.15.3. Scheme of Ca
2+
 influx into a lymphocyte. The maximum value represents the peak 
value of the Ca
2+
 influx curve upon lymphocyte activation, thus it reflects the maximal amount of 
[Ca
2+
]cyt in the course of activation. The time to reach the maximum value (Y, tmax) describes, how 
soon the peak value is reached. The slope reflects how rapidly the peak of Ca
2+
 influx is reached. The 
area under the curve (AUC) describes the full amount of [Ca
2+
]cyt during the whole period of 
lymphocyte activation. AUC values correspond to the sum [Ca
2+
]cyt increase, which further 
corresponds to the level of lymphocyte activation. (Adopted from Toldi et al., 2011) 
According to the second hypothesis on T cell activation, the lymphocyte must 
encounter several APCs presenting its specific antigen in the context of the MHC II. 
However, each of these contacts alone is insufficient to exceed the cytosolic calcium 
threshold concentration required for the final activation of the T cell. As illustrated in 
Figure 3.15.3, the rise in cytosolic calcium triggered by a single APC has a limited 
life time. This duration is a critical variable for modeling the T cell activation, as the 
gap between successful interactions of T cells and APCs needs to be shorter in 
order to steadily increase the intracellular calcium level. 
Experimental data on this time differ, depending on the method and cell type used 
(Lioudyno et al., 2008; Toldi et al., 2011). Most measurements were done for 10-
15 min, the time in which Ca2+ values significantly dropped. However, in the 
previously modeled scenario, a T cell needs an average time of 127 min to find an 
activating APC, which would be too long for second hypothesis to possibly lead to an 
activation event. To find a second activating APC in 10-20 min, the T cell would 
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require moving with a velocity of 25-40 µm/min, which is extremely fast (experimental 
velocity is 10 µm/min). It can be concluded that second hypothesis is not very likely, 
based on the assumptions that have been made. 
However, the experimental data used for the probability calculation are based on 
∆NFAT-GFP as a sensor for the final T cell activation event. Therefore, it does not 
indicate the Ca2+ influx, an early step of the activation pathway. However, the second 
hypothesis assumes, that T cells receive sub-maximal signals from different APCs 
on the way. If this is taken into consideration, the probability for finding the right APC 
would be much higher. 
For the second hypothesis to be possible, a T cell must find a stimulating APC in 
approximately 20 min or less. If the searching time is considered to be constant 
(20 min), it can be modeled how   (probability that a T cell/APC contact is 
stimulating), depends on mean displacement (Figure. 3.15.4). 
 
Figure 3.15.4. Mean displacement (∆x) dependency graph modeled in MATLAB with a constant 
Tfind of 20 min. Dependency of the probability (P) that a T cell/APC contact is stimulating from mean 
displacement with the assumption that the APC searching time is constant (20 min). Red circle on the 
graph represents the experimentally observed mean displacement (4.23 µm). 
The red circle in figure 3.15.4 indicates probability for experimentally determined 
velocity, and is 0.39, meaning that every 2-3 T cell/APC contacts must lead to Ca2+ 
influx, for the T cell to be able to accumulate a stimulus on the way. 
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3.15.4 Modeling T cell activation during antigen recognition and 
signal transduction 
It was assumed that besides for finding an APC, the T cell also has to spend energy 
on the process of activation during antigen recognition and signal transduction. It 
was defined before, that the total energy a T cell needs to spend on becoming 
activated, in the two discussed hypotheses is: 
Hypothesis I: 
        
      
  
       
     
  
      
Hypothesis II: 
         
      
  
       
     
  
      
    Number of short activating contacts that T cell must establish until the 
activation threshold is exceeded, leading finally to a full activation. 
From these equations can be concluded that, for the second hypothesis to be 
possible, the energy a T cell spends on antigen recognition and signal transduction 
must here be much less compared to the first case. Since it is considered that 
energy has linear dependency over time, these will be true if a T cell spends much 
less time for activation process itself in the second compared to the first hypothesis. 
It is also clear that in the second case the T cell will always spend N time more 
energy on finding the right APC. This imply that  the T cell can benefit in the second 
scenario only if the antigen recognition and signal transduction process is 
energetically more expensive than process of APC searching. In equations this 
would be: 
                if 
                and   
      
  
 
     
  
 
The first condition was modeled to test the feasibility of this scenario. For this, the 
Ca2+ influx kinetic graph was used (Fig. 3.15.3). Please note that tmax describes 
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how soon the peak value of the Ca2+ influx curve is reached, and that the Area 
Under the Curve (AUC), which corresponds to the sum of [Ca2+]cyt increase, further 
relates to the level of lymphocyte activation (Toldi et al., 2011). 
It is assumed here that a certain AUC is needed for the full activation of T 
lymphocyte. Using experimental data it was also suggested that the duration of one 
contact, leading to full T cell activation (     ), should be approximately 20 min. For 
further modeling in MATLAB, the approximation of the Ca2+ influx curve was used 
(Figure 3.15.5). 
 
Figure 3.15.5. Approximation of the Ca
2+
 influx curve, as used for modeling the activation in 
MATLAB. Graph depicts approximated kinetics of the Ca
2+
 influx and decay in one T cell/APC contact 
that would lead to a full activation. The area under the curve (AUC) was used as a constant needed 
for full activation, and the line at 200 s indicates tmax, which was variable in our model. 
Here, the AUC does not depend on tmax (only on height), implying that for one long 
activating contact it is not relevant how fast the maximum value is reached. 
However, this can be crucial for receiving a stimulus upon a short contact, why it was 
modeled how is   (Number of short activating contact needed for full activation) 
depending on tmax. This would directly give us information of the total time that 
T cells need to spend on their activation according to the second hypothesis (T2act), 
which can then be compared to T1act (assumption is 20 min). An average short 
contact between a T cell and an APC is, as it was already calculated, the time the 
T cell needs to simply pass by an APC (ts= 3.23 min). It is suggested that even 
during simple scanning whether or not the APC is presenting the appropriate 
antigen, the T cell will get a certain stimulus as Ca2+ influx. The stimulus intensity 
would correspond with the AUC value. The dependence of   and tmax (time needed 
for Ca2+ to reach its maximum value) was modeled in MATLAB (Figure 3.15.6). 
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Figure 3.15.6. tmax dependency graph. Graph depicts how the number of short contacts 
(ts=3.23 min) needed for full activation (AUC from the Figure 3.15.3), is depending on tmax. Red lines 
set the borders for second hypothesis to be possible using calculations (N*ts <T1act). The calculation 
was performed using MATLAB. 
Figure 3.15.6 illustrates that for small tmax (Ca2+ influx reaches maximum value 
fast), the T cell would need just a few contacts and hence less time (T2act), to 
become fully activated, comparing to one long contact (T1act). All this would imply 
that T cells can energetically benefit from the second hypothesis, presuming that 
Ca2+ influx reaches its maximum fast. 
It should also be mentioned, that the T cells would always spend more energy for an 
APC search in the second hypothesis ( x more). Therefore, in order to energetically 
benefit from the second scenario, the equation 
      
  
 
     
  
 must also be satisfied. 
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4 DISCUSSION 
In this study, T cell lines with distinct antigen-specificities, inducing either  severe 
(EAEhi),  or  marginal (EAElo) neurological disorder,  in different rat strains (LE vs 
DA), were used as a paradigm to investigate the role of CNS-associated antigen 
presentation in early stages of disease development. Intravital two-photon imaging 
approach demonstrated that the interaction between infiltrated T cells and local 
APCs residing in the leptomeninges are crucial for the formation of tissue infiltrates 
and for induction of clinical disease. In addition, a new fluorescent marker of T cell 
activation, truncated NFAT fused to GFP (∆NFAT-GFP) was applied, allowing, for 
the first time to visualize the autoimmune T cell activation in vivo. This approach 
unambiguously documented that T cell interactions with perivascular phagocytes, 
and not with endothelial cells, are essential for T cell activation. This work further 
emphasizes the impact of auto-antigen availability on the locomotor behavior and 
pathological capacity of CNS autoimmune T cells. 
Entry of myelin-reactive autoimmune T cells into the CNS involves a complex set of 
sequential interactions between T lymphocytes and their surrounding milieu, first in 
the periphery and then at the BBB. Following adoptive transfer, in vitro activated 
T cells first enter lymphatic organs where they assume a “migratory” phenotype, 
down-regulating activation markers and up-regulating chemokine receptors, which 
renders them competent to home into the CNS (Flügel et al., 2001). A recent study 
showed that T cells can also acquire migratory phenotype in the lung (Odoardi et al., 
2012). Once they arrive at their CNS entry port, the leptomeningeal vessels 
(Bartholomäus et al., 2009; Kivisäkk et al., 2009), the T cells attach to the luminal 
surface of the local vessels, first roll along, and then crawl, preferentially against the 
blood flow, before they pass through the endothelial wall (Bartholomäus et al., 2009). 
After extravasation the immigrant T cells continue to crawl on the abluminal side 
where they make contacts with perivascular phagocytes. It was hypothesized that 
these interactions facilitate the presentation of locally released auto-antigen to auto-
reactive T cells, directing them further into the CNS parenchyma. 
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The first structure encountered by CNS-homing T cells is the luminal membrane of 
meningeal vessels. In the CNS, blood vessel endothelium is highly specialized 
structure of the BBB. Apart from tight junctions, endothelial cells express a spectrum 
of surface molecules allowing them to attract blood leukocytes and communicate 
with them (Nourshargh et al., 2010). For instance, T cell rolling involves transient 
interactions between selectins and glycoproteins (Piccio et al., 2002), while crawling 
depends on the binding of integrins LFA-1 and VLA-4 (Bartholomäus et al., 2009). 
Here it was documented, that myelin-specific T cells, interact with the 
cerebrovascular endothelium remarkably similar, regardless of their encephalitogenic 
potential. They appear in the leptomeninges with similar kinetics, and show an 
undistinguishable locomotive behavior. All T cell types attached to intraluminal 
surfaces and crawled there with similar velocities and track patterns. Finally, by 
using ∆NFAT-GFP as a fluorescent marker of T cell activation, it was shown that 
neither the crawling nor the rolling T cells translocate NFAT into their nucleus. It is 
noteworthy to mention here, that due to the limited microscope scanning speed, only 
a fraction of fast rolling T cells was detected. These findings suggest that, 
unexpectedly, the inflammatory status of the perivascular milieu has little effect on 
the locomotion behavior and activation status of T cells, as long as they are inside of 
the vascular tube. 
However, the interactions of immigrant T cells with components of the extravascular 
leptomeningeal milieu differ depending on their pathogenic potential. It was noted 
that following diapedesis, the weakly encephalitogenic TLE-MOG cells fail to detach 
from the perivascular area of the leptomeningeal blood vessels, while highly 
encephalitogenic TLE-MBP and TDA-MOG cells left the perivascular area to evenly 
distribute throughout the leptomeninges. The key events underlying this discrepancy 
involved the interactions of T cells with local APCs, and the subsequent T cell 
activation. 
Real-time imaging demonstrated that EAEhi T cells show a lower motility and make 
longer contacts with local APCs, compared to the highly motile EAElo counterparts 
(average contact duration of EAEhi T cells was around 6 min, and of EAElo T cells 
3 min). Experiments using the ∆NFAT-GFP marker confirmed, that this discrepancy 
is directly correlated with the activation status of auto-reactive T cells. Namely, both 
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motility and APC contact duration of T cells that retained ∆NFAT-GFP in their cytosol 
(resting T cells) were indistinguishable (average contact duration is 3 min), 
regardless of their pathogenic potential. In contrast, T cells that translocated ∆NFAT-
GFP into their nucleus exhibited a reduced motility and engaged in longer contacts 
with meningeal phagocytes. ∆NFAT-GFP as a fluorescent marker of T cell activation 
allowed here for the first time to visualize the in situ activation of auto-reactive T cells 
and even to correlate it directly with APC interactions. T cell/APC contacts leading to 
∆NFAT-GFP translocation from the cytosol to the nucleus were also the longest 
interactions observed in leptomeninges (average duration of 20 min). 
Formation of short and long lasting contacts with APCs is a general phenomenon, by 
no means unique to the CNS. Mempel et al. suggested a three phase model of 
antigen recognition in the peripheral LNs (Mempel et al., 2004). They found that 
antigen-specific T cells formed multiple short lasting contacts with APC at an early 
stage of antigen-recognition (within 8 hours). In the subsequent period, between 8 
and 20 hours, T cells established longer lasting, stable contacts, which finally 
resulted in T cell activation. T cell/APC interactions that were observed here in the 
leptomeningeal area qualify as transient contacts and are similar to the interactions 
characteristic for the early stage of antigen recognition in the lymph node, while long 
lasting stabile contact (duration of approximately 1 h) were rare. 
Dustin et al. also distinguished stable contacts (“synapses”) from the transient 
interactions (“kinapses”), of T cells encountering exogenous antigens in secondary 
lymph organs (Dustin, 2008). According to this scheme, most of the APC contacts 
formed by the EAEhi T cells in the leptomeningeal space qualify as kinapses (motility 
between 2.5 and 5.0 μm/min), whereas synapses (motility slower than 2.5 μm/min) 
were rarely observed. Both the kinapses and synapses might be sufficient to 
translocate NFAT to the nucleus and to induce the transcription of activation-
dependent genes (Moreau et al., 2012). Elevation of intracellular calcium levels and 
following NFAT translocation are considered to be a stop-signal to T cells 
(Negulescu et al., 1996). However, this seems not to be the case in the 
leptomeningeal EAEhi T cells, which continued to visit APCs successively even in the 
activated, ∆NFAT-GFP nucleus-localized state. This supports a previous suggestion 
(Bartholomäus et al., 2009), that contacts with leptomeningeal APCs serve to guide 
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immigrant autoimmune T cells into the CNS parenchyma rather than to arrest them 
for longer time periods. 
Which factors determine the duration of T cell/APC contacts, and how are they 
related to the encephalitogenic potential of the T cell? The responsiveness of a T cell 
depends on the structure of the specific antigen receptor, and its surrounding co-
activating and signal transducing machinery. Indeed, a slightly lower sensitivity of 
TLE-MOG cells to low doses of antigen presented by professional APCs in vitro was 
noted, compared to other T cell lines. This might particularly account for antigen 
presentation by leptomeningeal APCs, which are not saturated with myelin antigens 
(Bartholomäus et al., 2009; Odoardi et al., 2007a). 
However, the encephalitogenic potential of EAElo TLE-MOG cells is demonstrable by 
supplying exogenous MOG. Intrathecal administration of MOG-loaded APCs lowered 
the motility, and extended contact duration of EAE lo T cells with APCs, making their 
behavior similar to that observed in EAEhi T cells. In addition, local infusion of MOG 
induced ∆NFAT-GFP translocation in EAElo T cells from the cytosol to the nucleus, 
and showed that, like in EAEhi T cells, both motility as well as duration of T cell/APC 
interactions could be directly correlated with the activation status of the T cells. 
Increased antigen availability and following T cell reactivation in leptomininges were 
associated with the development of clinical EAE. 
This brings the attention to local meningeal APCs and their possibly insufficient 
ability to present auto-antigen to T cells. When isolated ex vivo, these phagocytes 
can indeed present locally produced myelin auto-antigens to specific T cells, but the 
antigenic strength in vitro is weak. The responding T cells are activated to release 
cytokines, but do not extensively proliferate unless supplemented with exogenous 
antigen (Bartholomäus et al., 2009). Meningeal APCs isolated from Lewis rats (LE) 
weakly present MOG to cognate T cells, but at the same time are efficient presenters 
of MBP, which excludes a strain-related defect in antigen presentation. Similarly, 
MOG is a weak encephalitogen in LE, but a strong in DA rats, ruling out a global 
reduction of auto-antigenic strength in rats. However, the level of locally produced 
MOG may be lower in LE than in DA rats (Pagany et al., 2003). To explore this 
possibility, we transferred TLE-MOG-GFP or TDA-MOG-GFP cells into F1 (LExDA) hosts. The 
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behavior of both cell types in F1 hosts mirrored the one in parental rats. TDA-MOG cells 
showed lower motility and prolonged contacts with local APCs, compared to TLE-MOG 
cells. TDA-MOG cells also induced stronger EAE than TLE-MOG cells in F1 host. 
Therefore, differences in clinical severity are not due to host properties. A further 
explanation might be different epitope presentation in context of MHC class II 
molecules. Weissert et al. demonstrated that Lewis rats and congenic rats sharing 
their MHC class II haplotype were largely protected from EAE induction by 
MOG/CFA immunization (Weissert et al., 1998). They found that the minimum 
amount of MOG required to induce EAE depended directly on the MHC haplotype. 
According to their hypothesis, the MHC haplotype dictates binding of MOG-peptides 
to the relevant MHC class II protein, which is in line with our finding. 
Intravital two-photon microscopy revealed that EAElo T cells penetrated into the CNS 
leptomeninges similarly to EAEhi T cells. However, they were engaged in only short 
contacts with local APCs, which failed to induce the translocation of ∆NFAT-GFP 
from cytosol to nucleus. As a result, they are not receiving the “go ahead” signal, 
allowing them to detach from the vessels and infiltrate the parenchyma. However, an 
increase of antigen availability on local APCs induced ∆NFAT-GFP translocation 
from the cytosol to the nucleus in EAElo T cells and recruited them into the CNS, 
leading to induction of clinical symptoms. The work by Hickey and Kimura indicated 
that bone-marrow derived perivascular cells are the essential elements interacting 
with encephalitogenic T cells to induce clinical EAE (Hickey and Kimura, 1988). In 
mice, these local meningeal APCs express markers of dendritic cells (Greter et al., 
2005), while in rats their profile places them closer to macrophages (Bartholomäus et 
al., 2009). This discrepancy may be explained by species differences. Nevertheless, 
it was confirmed here and by others, that these APCs can in vitro present 
endogenous antigen to infiltrated T cells. Indeed, in vivo two-photon imaging showed 
that T cell reactivation by local APCs in leptomeninges is a major check-point for 
T cell infiltration into the parenchyma, and implicitly for induction of clinical EAE. This 
result might lead to novel therapeutic strategies for MS, which specifically block the 
infiltration of autoaggressive T cells into the CNS without modifying host immunity, 
and the method introduced here can be suitable for testing the same. 
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A truncated NFAT1 fused to GFP (∆NFAT-GFP), used here as fluorescent reporter 
of in vivo T cell activation, represents an important technical advance. ∆NFAT-GFP 
displays qualities rendering it more suitable for two-photon imaging of T cell 
activation, than the various previously suggested activation indicators. Among these, 
TCR complex related genetic markers, such as a CD3zeta-GFP fusion protein 
(Huppa et al., 2003; Richie et al., 2002; Yudushkin and Vale, 2010), or Linker for 
Activation of T-Cells (LAT)-GFP fusion protein (Tanimura et al., 2003), showed T cell 
activation by clustering at the immunological synapses. However, due to the poor z-
resolution (typically, 3-4 μm spacing) of two-photon microscopy, detection of small 
clusters within three-dimensional volume is not reliably possible. In contrast, ∆NFAT-
GFP subcellular localization was detectable in more than 90% of the T cells during 
intravital two-photon imaging. Moran and colleagues used GFP expressed from the 
immediate early gene locus, NUR77, as activation indicator (Moran et al., 2011). 
This system can distinguish the strength of TCR stimulation according to GFP 
expression level. However the GFP protein needs to be transcribed and maturated, a 
process that takes at least few hours, which is too long for real-time imaging of T cell 
activation. In sharp contrast, ∆NFAT-GFP nuclear translocation occurs within only 
few minutes after stimulation. Finally, calcium indicators can be used to monitor 
T cell activation in vivo (Wei et al., 2007). Small molecular calcium indicator dyes are 
rapidly pumped out from T cells and thus fail to label them over extended periods of 
time. Recently, a genetically encoded Ca2+ indicator, Twitch-1, has also been 
developed as a marker of in vivo T cell activation (Mues et al., 2013). However, 
∆NFAT-GFP is a robust downstream indicator, as elevated calcium might not always 
result in full T cell activation. Considering all this, the ∆NFAT-GFP fusion-protein 
qualifies as a marker to rapidly and reliably detect T cell activation induced by 
antigen recognition in vivo. 
In CD4+ T cells, NFAT family proteins act as key factors of Ca2+ controlled gene 
transcription. Following TCR engagement and increased intracellular calcium levels, 
calcineurin dephosphorylates NFAT, which then translocates from the cytoplasm to 
the nucleus where, in cooperation with other transcription factors, it binds to the DNA 
in order to initiate gene expression. However, although ∆NFAT-GFP is a reliable 
indicator of TCR/calcium-dependent cell activation, it is not absolutely specific. Apart 
from TCR activation, the pathway may also be triggered via signaling through 
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cytokine receptors such as IL-2R and IL-15R (Barlic et al., 2004) or IL-6R (Diehl et 
al., 2002). Conversely, T cells may be stimulated via alternative pathways, which 
would not be indicated by ∆NFAT-GFP (Macian, 2005). In addition, a truncated 
version of the NFAT1 protein, which is only one out of three variants expressed in 
CD4+ T cells (NFAT2 and NFAT4), was used here. This must be considered in the 
case of the intraluminal T cell migration modes for which no ∆NFAT-GFP 
translocation was observed. The negative finding of NFAT transition may exclude the 
classic TCR-mediated, NFAT1-driven activation, but not necessarily distinct 
stimulatory pathways with or without TCR participation. For instance, 
dephosphorylated NFAT2 translocation might also drive transcription of activation 
genes, and integrin-dependent stimulation can elevate Ca2+ levels but may not 
induce NFAT translocation. For this purpose, the recently developed Twitch-1 would 
be more suitable (Mues et al., 2013). 
At the end it was attempted to test two existing hypotheses on T cell activation , 
using the motility data obtained from two-photon imaging in combination with a  
theoretical, physicist approach. The first hypothesis assumes, that after finding an 
APC with the right antigen, the T cell will interact with it, until becoming fully 
activated, while the second one suggests that a T cell will collect its activation signal 
on the way, without establishing long contacts with APCs. Our basic assumption is 
that T cells would prefer the energetically cheaper concept. 
It is proposed that, in order to become activated, a T cell must spend energy first on 
finding an activating APC, and then on the activation itself during antigen recognition 
and signal transduction. We show that the total energy a T cell needs to spend on 
finding the right APC, depends on T cell velocity, and the probability that an 
APC/T cell contact is an activating one. Using experimental data, based on 
fluorescent T cell activation sensor, it could be calculated that a T cell needs to 
contact on average 16 APCs to find a right one. For this, considering the 
experimentally calculated velocity of 10 μm/min, the T cell requires around 2 h. From 
the kinetics of T cell activation, that have been previously reported (Shaw et al., 
1995; Toldi et al., 2011; Tomida et al., 2003), showing that the levels of influxed Ca2+ 
ions drop to basal values in approximately 20 min, it would be very unlikely that 
T cells can accumulate the calcium signal with 2 h difference between receiving the 
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triggers. Therefore, the first hypothesis would be more likely for the leptomeningeal 
reactivation of autoimmune T cells by local APCs. 
Furthermore, conditions under which the second hypothesis would be preferable, 
were explored. It was calculated that for the second scenario to be possible, a T cell 
must have much higher probability of finding the right APC (0.4). Concentration of 
the specific antigen can have a major impact on this. As already mentioned, 
meningeal APCs are not saturated with myelin antigen, and external addition of 
antigen can improve their activating potential (Odoardi et al., 2007a). Form this, it 
can be concluded that there is low probability of meningeal APC being the right one. 
However, in draining lymphoid organs the concentration of pathogenic antigen can 
reach very high levels, to ensure a strong immune response against it. It should be 
also taken into consideration, that meningeal APCs could have lower density, 
compared to dendritic cells in lymph nodes. This factor can affect the APC search-
time, rendering the second hypothesis more likely (Bousso and Robey, 2003). 
Overall, both hypotheses could be possible, depending on specific conditions in 
which T cells are receiving their activation signal. It is likely that T cells can become 
activated in both ways and that depending on antigen concentration and APC 
density they will do that by following the first or the second hypothesis. Here, it is 
suggested that in the immunoprivileged organs such as the CNS, T cells are 
activated most likely according to the first hypothesis. This work also offers a new, 
physical approach for solving immunological questions. 
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ABBREVIATIONS 
∆NFAT truncated NFAT 
aa  amino acid 
aEAE  active EAE 
APC  Antigen Presenting Cell 
AUC  Area under the curve 
BBB  Blood-Brain-Barrier 
BN  Brown Norvergicus 
c  cytosolic 
CaM  Calmodulin 
CD  Cluster of differentiation 
CFA  Complete Freund’s Adjuvant 
CK  Casein kinase 
CNS  Central Nervous System 
ConA  Concanavalin A 
CRAC  Calcium release activated calcium 
CsA  Cyclosporine A 
CTLA  Cytotoxic T Lymphocyte Antigen 
DA  Dark Agouti 
DC  Dendritic cells 
DMEM Dulbecco´s Modified Eagle´s Medium  
DMSO Dimethyl Sulfoxide  
EAE  Experimental Autoimmune Encephalomyelitis 
EAEhi  High encephalytogenic 
EAElo  Low ancephalytogenic 
EBV  Epstein bar virus 
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ECG  Electrocardiogram 
EDTA  Ethylenediaminetetraacetic acid 
EH  Eagle’s HEPES 
ER  Endoplasmic Reticulum 
F1  First generation 
FACS  Fluorescence-activated cell sorting 
FCS  Fetal calf serum 
GFP  Green Fluorescent Protein 
GSK  Glycogen-synthase kinase 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HLA  Human leukocyte antigen 
ICAM  Inter-Cellular Adhesion Molecule 
IFNγ  Interferon gamma 
Ig  Immunoglobulin 
IL  Interleukin 
IS  Immunological Synapse 
ITAM  Immunoreceptor tyrosine-based activation motif 
ITK  IL-2 inducible T cell kinase 
LAT  Linker for the activation of T cells 
LCK  Lymphocyte-specific protein tyrosine kinase 
LE  Lewis 
LFA  Lymphocyte function-associated antigen 
LPS  Lipopolysaccharide 
MBP  Myelin basic protein 
MCP-1 Monocyte chemoattractant protein-1  
MHC  Major Histocompatibility Complex 
MIP-1  Macrophage inflammatory protein-1 
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MOG  Myelin oligodendrocyte glycoprotein 
MS  Multiple Sclerosis 
MSD  Mean square displacement 
n  nuclear 
N.D  Not detected 
nc  nuclear/cytosolic 
NFAT  Nuclear Factor of Activated T cells 
NHR  NFAT homology region 
NLS  Nuclear localization signal 
ns  Not significant 
OCB  Oligoclonal bands 
OSE  Opticospinal EAE 
OVA  Ovalbumin 
PBS  Phosphate buffer saline 
PCR  Polymerase chain reaction 
PFA  Paraformaldehyde 
PLC  Phospholipase C 
PLP  Proteolipid protein 
PMA  Phorbol 12-Myristate 13-Acetate 
PPMS  Primary Progressive MS 
PRMS  Progressive Relapsing MS 
RHR  REL-homology domain 
RRMS Relapsing Remitting MS 
RT1  Major Histocompatibility Complex of the Rat 
RV  Robin Virchow space 
p.t.  post transfer 
S.D  Standard deviation 
ABBREVIATIONS 
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SLP  SH2 domain containing leukocyte protein 
SMAC  Supramolecular activation complexes 
SNARF Seminaphthorhodafluor  
SOCE  Store operated calcium entry 
SP  SPXX-repeat motifs 
SPMS  Secondary Progressive MS  
SRC  Sarcoma tyrosine kinase 
SRR  Serine-rich regions 
TAD  Transactivation domain 
TCGF  T cell grow factor 
TCM  T cell medium 
TCR  T cell receptor 
tEAE  transfer EAE 
TNF  Tumor necrosis factor 
VLA-4  Very late antigen-4 
ZAP  Zeta-chain-associated protein kinase 
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